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ABSTRACT OF DISSERTATION

THE INFLUENCE OF PHYSICAL HEALTH, EMOTIONAL HEALTH, AND
SOCIOECONOMIC FACTORS ON THE MUSCULOSKELETAL PAIN EXPERIENCE
IN PATIENTS ATTENDING A PRO BONO PHYSICAL THERAPY CLINIC
Non-communicable, chronic diseases are highly prevalent in the United States,
reducing the quality of life for those affected and contributing to the majority of the
nation’s healthcare expenditure. These conditions include, among others, cardiovascular
disease, diabetes, and musculoskeletal disease. Musculoskeletal disease is particularly of
interest for the field of physical therapy as the vast majority of patients seeking care in
the outpatient setting present with musculoskeletal pain complaints, resulting in
limitations in function, participation, and quality of life for the patient.
The factors influencing health outcomes are diverse and include a person’s
physical environment, social and economic factors, access to quality clinical care, and
health behaviors. Thus, managing chronic disease requires intervention at the level of the
patient, provider, healthcare organization, community, and the local, state, and federal
governments. Implementing multilevel intervention and advocacy can reduce the impact
of chronic disease and allow people to more meaningfully engage in their lives. The
purpose of this dissertation was to first describe a population attending a pro bono
physical therapy clinic for musculoskeletal pain complaints in the southeastern United
States in regards to measures of physical health, emotional health, socioeconomic status,
and pain presentation. These measures were then assessed to discover their usefulness in
identifying chronic disease as well as their ability to identify clinically-important patient
subgroups that may require a more tailored treatment approach. By understanding the
patient population more completely, future directions for addressing patient needs
through clinical intervention, clinical programming, and advocacy endeavors can be
implemented to produce more positive health outcomes.
Theoretical foundation for the management of chronic disease was informed by
the Innovative Care for Chronic Conditions framework (World Health Organization,
2002). The County Health Ratings Model (University of Wisconsin Population Health
Institute, 2019) and the Tool for Health & Resilience in Vulnerable Environments
(Prevention Institute, 2004) were used as guides in determining the important factors
influencing health outcomes and routes of intervention to improve health equity. Models
of the pathophysiology of metabolic syndrome (Eckel et al, 2005), a precursor to
cardiovascular disease and diabetes, and their impact on musculoskeletal disease (Collins
et al, 2018) were also considered to identify clinical measures in the physical therapy
setting that can better inform the clinician of the patient’s condition.

A clinically-based, standardized intake process was created and implemented at a
pro bono physical therapy clinic to capture measures of physical health, emotional health,
health behaviors, and social and economic variables. The measures chosen fall within the
scope of physical therapy practice and were selected to bolster the treating clinician’s
clinical decision making to provide patient-centered care. A retrospective chart review
was performed over a two-year period (December 2017 to December 2019) to collect
these data from the initial patient evaluation. Descriptive statistics were used to define the
population attending the clinic and their potential healthcare needs. Regression analysis
was then performed to determine which measures best inform the clinician regarding
metabolic disease status in this population and whether those at risk of metabolic disease
presented differently from those without. Finally, a latent class analysis was performed to
identify unique patient subgroups within those presenting to the clinic and the
distinguishing features of these subgroups.
KEYWORDS: Pro Bono Care, Chronic Disease, Chronic Pain, Physical Health,
Emotional Health, Socioeconomic Variables
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CHAPTER 1. CHRONIC DISEASE, METABOLIC SYNDROM E, AND P ERSISTENT
MUSCULOSKELETAL P AIN
1.1

Introduction
In the United States, many people are affected by non-communicable diseases

such as cardiovascular disease, diabetes, mental health conditions, and musculoskeletal
disease.1 Often considered to be diseases related to lifestyle, these conditions are
commonly and often incorrectly stigmatized as a result of health choices by the
individual while the role of the larger, societal issues driving health outcomes go
unacknowledged.2,3 While personal behaviors are an important factor in the development
of chronic disease, there are many external variables that impact a person’s ability to
engage with a healthier lifestyle.4
In Chapter One, these external factors will be presented, demonstrating that
management of chronic disease requires a systems-based approach.2 Health outcomes are
influenced not only at the level of the patient and provider, but also within the
organizational, community, and political environments.2 Thus, to create significant and
long-term health outcomes in those suffering from chronic disease and also those at risk
of developing chronic disease, intervention is needed at all levels influencing healthrelated outcomes.3,4 No single provider has the resources necessary to prevent and/or
manage chronic disease.5 Proper management requires an interdisciplinary team with
each member providing expertise in their domain, and physical therapists are wellpositioned to be a contributing member of this interdisciplinary team.6 In the outpatient
setting, the majority of patients present to physical therapy with musculoskeletal
complaints.7,8 However, many of the same patients present with comorbid, chronic

disease or are at risk of developing chronic disease.9 Therefore, as an interdisciplinary
team member, physical therapists must be aware of the importance of screening for
chronic disease, not only as it relates to morbidity and mortality, but also the impact
comorbid chronic diseases can have on the rehabilitation of diseases of the
musculoskeletal system.10 While physical therapists specialize in human movement,11 a
whole-person, patient-centered approach must be considered to optimize not only
outcomes related to the musculoskeletal system, but also improve the overall quality of
life of this patient population.
Chapter Two will discuss the risk factors for developing chronic disease and the
overlap with the risk factors for developing musculoskeletal diseases. As an appreciation
for the biopsychosocial variables impacting musculoskeletal disease has grown within the
physical therapy profession, classification systems to guide clinical reasoning and patient
management have evolved to consider not only impairments related to movement, but
also underlying pain mechanisms, psychosocial variables, and the impact of physical
health.12 However, there continues to be a lack of consensus regarding which measures
are most effective in capturing these domains. Many instruments are available to screen
for and capture domains related to socioeconomic health, emotional health, and physical
health variables, with many of the physical health measures demonstrating relationships
with overall risk of morbidity and mortality. Further investigation of these measures are
warranted to determine the needs of specific populations as well as to discover which
measures best inform management strategies for patients with musculoskeletal disease. A
better understanding of the key variables impacting the patient presentation will lead to
more precise prescription of intervention at the patient and provider level as well as
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identify key issues related to advocacy that can be used to create change at
organizational, community, and political levels to promote long-term improvements in
health and quality of life for those most at risk for chronic health issues.
Managing chronic disease, including chronic musculoskeletal pain, can be a
difficult task.13 The content presented in Chapters One and Two will support the need for
further research in specific clinical populations with chronic disease and musculoskeletal
pain, which is the purpose of this study. First, this study will be assessing the physical,
emotional, and socioeconomic health of a population attending a pro bono physical
therapy clinic to identify the specific needs of the population to inform interdisciplinary
care strategies, healthcare programming, and advocacy endeavors that can address these
needs. Next, the ability to clinically identify the presence of chronic disease, specifically
metabolic syndrome, will be investigated to determine if additional measures of physical,
emotional, and socioeconomic health can help practitioners recognize those patients atrisk of having metabolic syndrome. Being at-risk or not-at-risk for metabolic syndrome
will then be used as a sub-classification of the clinical population to determine between
group differences exist in the domains of physical health, emotional health,
socioeconomic health, and the pain experience. Should such differences be discovered,
consideration of interventions to improve the risk factors associated with metabolic
syndrome may be important to improving clinical outcomes for those at-risk of metabolic
syndrome. Last, using measures of pain, physical health, and emotional health, novel
subgroup discovery will be performed to determine if unique presentations exist within
the population attending a pro bono physical therapy clinic which ultimately could inform
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a more targeted management strategy to meet the specific needs of the individual subgroups.

1.2

Chronic Disease and Management
Non-communicable diseases are often chronic conditions that reduce quality of

life for those affected as well as burden the systems managing those impacted by these
conditions. In the United States, non-communicable diseases are responsible for 89% of
deaths and 85% of disability-adjusted life years (DALY), which are years lost to illness,
disability, or death.1 Chronic physical and mental health conditions also accounted for
90% of the $3.5 trillion in healthcare expenditure in the United States in 2017.14-16 The
prevalence of chronic disease is high, as 60% of Americans have one chronic disease and
approximately 40% of the population have two or more.14,15 The five leading noncommunicable diseases in the United States include cardiovascular disease, cancer,
chronic respiratory disease, diabetes, and mental health conditions.1 Other noncommunicable diseases include liver disease, digestive disease, urogenital disease, blood
disease, endocrine disease, and musculoskeletal disease. It is estimated that noncommunicable diseases will create a total economic loss of $94.9 trillion in the United
States over the time range of 2015-2050.1 Only 39% of this estimate is related to
treatment cost, with the remainder related to the economic impact of morbidity and
mortality of the disease.1 It is therefore important for healthcare infrastructure in the
United States to develop efficient and effective systems to improve outcomes and quality
of life for patients with chronic diseases.

4

Currently, the healthcare system in the United States is not well-structured for
managing chronic conditions.13 Healthcare services have been designed around an acute
care, communicable disease model and change is needed to increase patient engagement
through provider interactions, community resources, and incentives in reimbursement to
manage chronic conditions.2 Most patients with chronic conditions are managed by a
primary care physician.13 However, there is a growing shortage of primary care
physicians in light of the aging population.5 A projected shortage of between 21,100 and
55,200 primary care physicians is expected by 2033.17 On average, primary care
physicians spend 17% of their time on preventive clinic visits, 37% managing chronic
complaints, and 46% assessing acute complaints.18 Thus, there is a need for an
interdisciplinary team that can reduce the burden on primary care physicians to help
manage those with chronic conditions.
Recognizing the challenge of managing chronic conditions, the World Health
Organization (WHO) expanded the Chronic Care Model developed by Wagner et al19 to
become the Innovative Care for Chronic Conditions framework.2 This model describes
“eight essential elements for taking action” in chronic disease management which
include, (1) supporting a paradigm shift, (2) managing the political environment, (3),
building integrative health care, (4) aligning sectoral policies for health, (5) using health
care personnel more effectively, (6) centering care on the patient and family, (7)
supporting patients in their communities, and (8) emphasizing prevention.2 The goal of
this framework is to create an integrated triad between the patient/family, health care
teams, and community supporters that all play an important role in management of
chronic conditions. Organizational, community, and political environments impact how
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each part of the team can engage with their role and thus leadership and advocacy is
needed to support policies that maximize health outcomes. Managing chronic conditions
requires the proper training and support at many different levels. The WHO continues to
use this model to manage chronic diseases to improve health-related outcomes and
demonstrate return on investment through savings in healthcare spending and reducing
the economic impact of morbidity and mortality.

Figure 1.1: Innovative Care for Chronic Conditions Framework2

1.3

Case Example: Guilford County, North Carolina, and Pro Bono Physical Therapy
Care
A systems-based approach to managing chronic conditions is necessary as health

outcomes are impacted by many different variables. The County Health Rankings and
Roadmaps program is a collaboration between the Robert Wood Johnson Foundation and
6

the University of Wisconsin Population Health Institute. Having identified key factors in
health outcomes, a weighting analysis was performed to create the County Health Ratings
Model.4

Figure 1.2: The County Health Rankings and Roadmaps Program20
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As is presented, health outcomes are determined by more than just the patient’s
health behaviors. Physical environment, social and economic factors, and access to
quality care account for 70% of health outcomes. These are important considerations not
only for advocacy and structural change but also for boosting understanding and empathy
in patient-provider interactions. Another Robert Wood Johnson Foundation
commissioned group, the Prevention Institute, recognizes the multifaceted determinates
of health.3 which includes structural drivers, community determinants, and quality
healthcare in moving toward health equity. Making the structural drivers, community
determinants, and quality healthcare more equitable in the population, negative health
behaviors and exposures can be reduced, ultimately decreasing the prevalence of certain
health conditions and raising the health and quality of life for the population as a whole.

Figure 1.3: Trajectory from Health Inequity (A) to Health Equity (B)3
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Table 1.1: The Interaction Between Determinates of Health, Behaviors and Exposures,
and Medical Conditions3
Determinates of Health →
Structural Drivers
 Inequitable distribution of
power, money, opportunity,
and resources
 Disempowered people
Community Determinants
Social-cultural environment
 Social networks & trust
 Participation & willingness
to act for the common good
 Norms & culture
Physical/built environment
 What’s sold & how it’s
promoted
 Look, feel, & safety
 Parks & open spaces
 Getting around
 Housing
 Air, water, & soil
 Arts & cultural expression

Behaviors & Exposures →
Tobacco/smoking
Excessive alcohol
Diet/nutrition
Physical activity
Chemical exposures
Air pollution
Sexual behaviors
Infections
Pollens & dust
Automobiles
Falls
Poisoning
Weapons
Violence
Drug use & abuse
Trauma and adverse
experiences

Medical Conditions
Heart disease
Cerebrovascular
Diabetes mellitus
Malignant neoplasms
Chronic lower
respiratory disease
Unintentional Injury
Suicide
Homicide
HIV
Infant mortality
Liver disease
Nephritis
Mental health
conditions and
trauma
Occupational
exposures
Drug/substance use
& abuse

Economic environment
 Education
 Living wages & local wealth
Quality Healthcare

Improving the distribution of power and resources and providing access to healthy
community conditions and quality healthcare will create a more empowered community
to engage in healthier behaviors, decreasing the presence of medical conditions and
improving the gap in health inequities between populations with different socioeconomic
9

backgrounds.3 Again, the importance of change at the level above health exposures and
behaviors is highlighted.
In order to make sustainable health impacts in a community, it is important to
understand the community itself. Guilford County is located in the Piedmont region of
North Carolina. Each year, the Guilford County Department of Health and Human
Services, along with partners within local healthcare systems and other community
organizations, publish a Community Health Assessment.21 to capture the current status
and future needs to improve health in Guilford County. This assessment compiles and
analyzes data from local to national sources, ranging from community surveys, local
public health research, state databases, and national databases. The North Carolina
Department of Health and Human Services, and its divisions of Public Health and the
State Center for Health Statistics, release county specific data via the County Health Data
Book22 and the North Carolina Electronic Disease Surveillance System.23 County
information was also gathered from the American Community Survey performed by the
United States Census Bureau24 and the Behavioral Risk Factor Surveillance System from
the County Health Rankings.25 Local perspective of health and wellness was captured
through on-line and in-person surveys of “key informants” in the community carried out
by the Community Health Assessment team members.21 Together, this information
provides important information about the current health of the county as a whole, as well
as key targets for intervention to raise the health and quality of life for every
demographic within the community.
Health outcomes have been found to be inequitable for different demographics of
Guilford County. Estimates describe 55.8% of the population as White, 33.8%
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Black/African American, 4.9% Asian, and 6.5% of another race.21 Regardless of race,
those identifying as Hispanic or Latino make up an estimated 7.8% of the population.21 In
2017, chronic diseases such as cardiovascular disease and cancer accounted for over 50%
of deaths in the county.21 Disparities in mortality related to chronic diseases were noted,
with Black/African American residents having higher age-adjusted mortality rates for
most chronic diseases compared to White residents.21 Life expectancy is lower within the
county in census tracts with higher percentages of Black/African American residents,
higher rates of poverty, and low rates of educational achievement, with some census
tracts demonstrating as much as a 20-year shorter life expectancy.21 Thus, while chronic
diseases can affect all residents of Guilford County, particular demographics of the
population are much more severely affected by these conditions.
As noted in both the County Health Ratings Model and the Prevention Institute
diagrams, health outcomes are driven by more than just health behaviors alone.3,4 Access
to quality healthcare can account for 20% of health-related outcomes.4 In Guilford
County, 11.3% of the population have no form of health insurance.21 Again, disparities
are seen between demographics, with 8.5% of Whites, 13.5% of Black/African
Americans, and 30.5% of Hispanics having no form of health insurance.21 Residents in
census tracts with a higher percentage of racial minorities, higher rates of poverty, and
lower educational attainment were less likely to have health insurance.21 Lack of
healthcare access is an issue for both physical and emotional health in the community. In
a survey of community members, the most commonly identified barrier to receiving
proper mental healthcare in the county was limited access to mental health services due to
a lack of resources, a lack of funding for mental health programs, a lack of providers,
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limited services for the uninsured population, and expensive co-pays in the insured
populations.21 Therefore, improving access to quality healthcare is a necessary
component to improving health outcomes in Guilford County, particularly in lower
socioeconomic populations.
Nutrition and exercise are important factors in the development of chronic
diseases and engagement with healthy eating and physical activity guidelines are
dependent on much more than individual behavioral choices.26 The percentage of adults
with obesity in Guilford County is 31% and those experiencing food insecurity is at
19%.21 Twenty-six of the 119 census tracts are food deserts, meaning that 20% of
residents live below the poverty level and one-third of residents live more than one mile
away from a full-service supermarket.21 These areas also overlap with the mapped areas
having higher rates of mortality due to heart disease.21 Additionally, as many as 38% of
the households in food desert areas in the county have no access to a personal vehicle,
increasing the difficulty of obtaining healthy food options.21 In a survey of residents of
the county, the most commonly reported barriers to healthy eating were the cost of
healthy food and the lack of access to healthy food outlets.21 Therefore, improving access
to healthy foods that are not cost prohibitive may improve community health outcomes.
Similarly, societal barriers are also seen with physical activity. Of adults in Guilford
County, 22% report no leisure time physical activity.21 Safety issues, including crime and
traffic, were the most commonly reported barriers to physical activity.21 With residents
feeling safer exercising indoors, cost of exercise facilities was also a commonly cited
barrier to exercise, and, for those unaccustomed to exercise or those starting from a place
of being out of shape or overweight, not knowing how to start a physical activity program
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was commonly described.21 Improving access to structured physical activity opportunities
for those with limited environmental options or those uncertain of how to begin
exercising can change health behaviors.
Education and economic health are also important considerations for improving
health outcomes.4 In Guilford County, 34.9% of adults have completed a Bachelor’s
degree or higher and the per capita income is $28,582.21 In lower income areas of
Greensboro and High Point, a much higher density of substandard housing is present
which increases environmental health risks.21 For example, areas of with higher densities
of substandard housing demonstrate higher rates of hospital admissions for asthma
complaints.21 A lack of safe, affordable housing was cited as the largest barrier to
improving housing conditions in a survey of county residents.21 More generally, surveyed
residents reported that the largest challenges to improving education and economic health
were found within inequalities of economic and political power as well as public policies
at the state or national level.21 Thus, leadership and advocacy are needed at the local,
state, and national levels of government to address disparities in the distribution of power
and resources to improve outcomes in chronic disease management.
Aware of the inequities in access to healthcare in the community, a physical
therapy pro bono clinic (PTPBC) was established in the region to provide full-time
clinical care to patients without medical insurance or those whose physical therapy
benefits have been exhausted. This endeavor was supported through community grant
funding and a clinical position was endowed through private donation. While the initial
goal of the clinic is to provide an access point to physical therapy for underserved
members of the community, long-term ambitions include engagement of the community
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beyond the office visit and advocating at professional and government levels to improve
access to healthcare, community conditions, and distribution of power and resources to
increase health equity. Over time, the clinic endeavors to create a sustainable model of
pro bono care and advocacy that can be adopted by organizations to improve health
equity in their own local communities. Also, the clinic offers opportunity for students
interested in healthcare fields to participate in experiences related to clinical care,
increasing the awareness of health inequities within the future practitioners and leaders in
healthcare. In order to progress on these goals, it will be important to assess the needs of
the patients utilizing the PTPBC as a healthcare resource to recognize opportunities to
improve interdisciplinary care, community engagement, and to support advocacy
initiatives.

1.4

The Role of Physical Therapy in Chronic Disease Management
Physical therapists can be an important ally in the management of patients with

chronic disease. Indeed, the American Physical Therapy Association (APTA) states in
their most recent vision statement:
Movement is a key to optimal living and quality of life for all people that extends
beyond health to every person’s ability to participate in and contribute to society.
The complex needs of society, such as those resulting from a sedentary lifestyle,
beckon for the physical therapy profession to engage with consumers to reduce
preventable health care costs and overcome barriers to participation in society to
ensure the successful existence of society far into the future.11

14

Through expertise in exercise prescription, health behavior change strategies, and health
education, physical therapists can promote patient engagement in self-management of
their condition.6 They can also provide information and referrals to community resources
designed to assist community members in engaging in healthier behaviors and/or
management of chronic disease. Thus, physical therapists can be an important member of
the interdisciplinary team managing patients with chronic disease, reducing burden on
primary care physicians and increasing access to healthcare for patients as the shortage in
primary care physician grows.
Physical therapists can also provide an access point into the healthcare system for
patients with complaints of musculoskeletal disease. The APTA continues to work
toward unrestricted direct access to physical therapy in the United States. While states
such as Nebraska have had unrestricted direct assess as early as 1954, currently 20 states
have unrestricted direct access.27 Of the remaining states, 27 have direct access with
provisions, and three states have limited direct access.27 Having direct access allows
patients to seek care from a physical therapist without the need of physician referral.
Through an initial evaluation, the physical therapist determines whether the patient is
appropriate for physical therapy care or whether referral for medical care is indicated.
Early research is indicating that patients utilizing physical therapy through direct access
demonstrated equivocal clinical outcomes with lower healthcare consumption which
ultimately reduced primary care physician burden.28 Related, a systematic review
analyzing the most common complaints of patients presenting to primary care physicians
in developed and developing countries found that back pain was the fourth most common
presentation, with arthritis being the sixth most common complaint.29 Therefore, physical
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therapists can be an ally in the management of chronic diseases and an access point for
patients with musculoskeletal pain complaints, decreasing the strain on primary care
physicians.
In the outpatient setting in the United States, the majority of patients seeking
physical therapy care present with musculoskeletal disorders. Using the data from the
Medical Expenditure Panel Survey from 1996 to 2000, it was found that 79.2% of
patients presented with non-traumatic joint disorders, sprains and strains, spondylosis,
intervertebral disk disorder, or other back problems.7 A study of Medicare beneficiaries
from 2006 to 2008 reported 71.3% of patients presented with disorders of the lumbar
spine, shoulder, and knee.8 Therefore, it is important for outpatient physical therapists to
have the skill and knowledge to manage musculoskeletal pain complaints. However,
many patients with musculoskeletal complaints in the United States are not presenting to
physical therapy with musculoskeletal pain alone. A study observing outpatient physical
therapy clinics across 22 states from 2005 to 2009 reported that of 2,375 patients, 9.2%
presented with diabetes, 15.7% with depression, 25.4% with headache, 30% with
hypertension, and 34.4% with obesity.9 Thus, whether physical therapists are managing
musculoskeletal pain in a direct access setting or as part of an interdisciplinary team, it is
important to screen and triage patients at risk of chronic disease, morbidity, and mortality
to provide patient centered care.

1.5

Metabolic Syndrome and Musculoskeletal Disease
As a part of management of the whole patient, it is essential to identify those at

risk of having or developing chronic disease. Metabolic syndrome (MetS) is a cluster of
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findings that increase a person’s risk of developing cardiovascular disease, diabetes, and
certain cancers. The diagnostic criteria for MetS includes measures of waist
circumference, blood pressure, serum triglyceride level, high-density lipoprotein level,
and blood glucose levels. While organizations have established different cut-off points
used for diagnosis, current guidelines include:30 (1) waistline of equal to or greater than
89 cm for women and 102 cm for men,31 (2) blood pressure of equal to or greater than
120/80 mmHg,32,33 (3) fasting triglyceride level equal to or greater than 150 mg/dL,31 (4)
high-density lipoprotein levels equal to or less than 50 mg/dL of women and 40mg/dL for
men,31 and/or (5) a fasting blood glucose level of 100 mg/dL or greater and HbA1c
greater than 5.7%.34,35 Using various cut-off points in these areas of risk, it has been
found that only 12.2-19.9% of Americans are metabolically healthy.30 This is significant
as it demonstrates that the vast majority of adults in the United States are at risk for
developing chronic disease.
The pathophysiology of MetS is not yet fully understood and is still being
extensively researched as it reaches across many different organ systems and human
biomes.10 However, a good starting point of reference is the development of an
abundance of adipose tissue, particularly abdominal adipose tissue.36 This results in an
increased release of free fatty acids which increase glucose production at the liver36,37 and
results in triglyceride accumulation and decreased glucose uptake in skeletal muscle.36,3840

Along with increases in hepatic glucose production, triglycerides and very low density

lipoproteins are also produced while a reduction in high-density lipoproteins
occurs.36,41,42 In response, the pancreas secretes more insulin, eventually creating insulin
resistance.36,43-45 These processes, along with an observed sodium reabsorption and
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increased sympathetic nervous system activity contribute to hypertension.36,46-50
Compounding these factors is the production of a pro-inflammatory state as adipose
tissue releases inflammatory cytokines, such as interlukein-6 and tumor necrosis factor
α,36,51,52 which further promote free fatty acid release,36,53 insulin resistance,36,53 and a
prothrombic state via the release of fibrinogen and plasminogen activator inhibitor-1
from the liver.36,54 Thus, insulin resistance, hypertension, and a prothrombic state set the
stage for the development of type II diabetes and cardiovascular disease.

Figure 1.4: Metabolic Syndrome
It is important for physical therapists to recognize MetS risk in an outpatient
population so that proper interdisciplinary management strategies can be initiated to
improve health and quality of life for the patient. However, a finding of MetS is also
significant to the patient presentation as it relates to musculoskeletal pain complaints. In a
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recent review, Collins et al outline the very detailed mechanisms in which the
pathophysiology of MetS also contributes to musculoskeletal disease.10 The metabolic
changes seen with an increase in free fatty acids, triglycerides, insulin resistance,
cardiovascular regulation, and a pro-inflammatory state can lead to impaired tissue
regeneration and structural adaptations in both muscle and bone,10,55-62 leading to a
reduction in integrity of these tissues that become pathoanatomical diagnoses such as
tendinopathy63 and osteoarthritis.64

Figure 1.5: Metabolic Syndrome and Musculoskeletal Disease
These musculoskeletal conditions can activate nocioceptive pathways secondary
to mechanical tissue irritation or inflammation and can result in changes in the peripheral
and central nervous systems that promote a pro-algesic state and subsequent increases in
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pain, loss of function, and further sedentariness.65-68 In turn, sedentariness can promote
even more metabolic distress,69 as sedentariness is a risk factor for metabolic disorder.70
Thus, in order to thoroughly manage a patient with both musculoskeletal and metabolic
disease, consideration of health behaviors, socioeconomic influences, and
interdisciplinary care strategies have to be incorporated. However, in a recently published
study surveying physical therapists on the APTA Orthopaedic Section email list
regarding cardiovascular disease screening, only 14.8% reported measuring blood
pressure and heart rate for each patient at the initial examination.71 Lack of time and lack
of perceived importance were cited as the main barriers to screening for cardiovascular
disease.71 Therefore, in order to change clinical behaviors to align with best practice
strategies to improve outcomes for patients with metabolic disease and musculoskeletal
pain, screening procedures must not be over-burdensome and their importance must be
highlighted for practicing clinicians.
Improving the provider’s ability to understand and screen for chronic disease and
its socioeconomic and psychosocial underpinnings is particularly important when
managing patients with persistent musculoskeletal pain (PMP) which affects more than
100-million Americans.72 This number equates to approximately one in every three
people in the United States. In other terms, more people in the United States are
experiencing PMP compared to those with heart disease, cancer, and diabetes
combined.72 It is estimated at 20.4% of the population in the United States suffers from
chronic pain, with 8.0% suffering from chronic pain that limits life or work activities
most days.73 Because of this, annual economic costs related to PMP are exorbitant.
Estimates from the early 2010s placed this burden at $560 to $635 billion dollars
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annually.74 and therefore current costs likely exceed this amount. Practitioners searching
to ease the suffering of this patient population have often resorted to improper
management, such as the use of opioid medication, leading to even more harmful
sequelae. Opioid medication was previously considered to be an effective and safe
intervention for PMP.75 However, more recent research has identified the danger of
prescription opioid use. Addiction to prescription opioids with long-term use occurs in as
many as one in four patients.76 In 2015, of the 52,404 deaths in the United States from
drug overdose, 33,091 involved an opioid.77 To date, the cost of the opioid epidemic to
the United States has been estimated to be at least $631 billion, with the 2019 costs
projecting at $172 to $214 billion.78 Thus, given the vast prevalence of PMP and the
associated inordinate costs, it is imperative to identify meaningful, cost-effective, and
non-opioid interventions to reduce the suffering in this patient population.

1.6

Summary
Chronic disease management is impacted by much more than individual health

choices. Models for managing chronic diseases must incorporate intervention strategies at
all levels impacting health outcomes, from patient/provider interactions to the larger
socioeconomic barriers preventing health equity. Management of chronic disease requires
an interdisciplinary team, of which physical therapists can play an important role.
However, in order to be more effective in this role, physical therapists must understand
the models of chronic disease management and their influence on musculoskeletal
disease in order to be able to provide whole person, patient-centered care.
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CHAPTER 2. RISK FACTORS, CLASSIFICATION SYSTEM S, AND CLINICAL MEASURES
Metabolic syndrome is a risk factor for developing cardiovascular disease,
diabetes, and musculoskeletal disease. Chapter Two will discuss the risk factors for MetS
that have been investigated in the literature and demonstrate how these risk factors mirror
those that predict the development of musculoskeletal disease. Identification of these risk
factors has created a greater appreciation for the biopsychosocial variables influencing
musculoskeletal disease, causing a shift in physical therapy classification systems to
include not only movement impairments, but also underlying neurophysiological pain
mechanisms and psychosocial variables. Thus, further investigation into measures of
socioeconomic status, emotional health, and physical health are needed to develop best
practice guidelines for the evaluation of patients with musculoskeletal disease and
chronic disease to inform more tailored intervention strategies.

2.1

Modifiable Risk Factors for Metabolic Syndrome
Aside from the physiologic measures of waist circumference, blood pressure,

triglyceride levels, high-density lipoprotein levels, and blood glucose levels, many
modifiable risk factors for the development of MetS have been investigated through
meta-analysis. Smoking has been found to increase the risk of developing MetS
(RR=1.26; 95% CI: 1.10-1.44) with male heavy smokers demonstrating even greater a
risk (RR=1.44; 95% CI: 1.27-1.59).79 Smoking cessation decreases the risk of MetS for
male smokers as former male smokers were found to have less risk (RR=1.19; 95% CI:
1.00-1.42) than actively smoking males (RR=1.34; 95% CI: 1.20-1.50).79 Therefore,

engaging patients with smoking cessation programs and resources can reduce the risk of
developing chronic disease.
Sedentariness also increases risk of developing MetS. Those reporting greater
amounts of sedentary behavior had increased odds of MetS (OR=1.73; 95% CI: 1.55 to
1.94).70 Similarly, those demonstrating high levels of leisure time physical activity were
found to have less risk of MetS80 (RR=0.80; 95% CI: 0.75-0.85) and those meeting the
physical activity guidelines of 150 minutes of moderate physical activity per week
reduced their risk of MetS by 10% (RR=0.90, 95% CI: 0.86-0.94).81 Even greater risk
reduction was seen in those engaging in moderate physical activity at twice (RR=0.80;
95% CI 0.74-0.88) and seven times (RR=0.47; 95% CI: 0.34-0.64) the physical activity
guidelines.81 Therefore, increasing physical activity participation based on patient
preference and tolerance can be a target for reducing metabolic distress.
Emotional health is also an important consideration in the development of MetS.
When adjusting for demographic factors, smoking, physical activity, functional capacity,
and beta blocker use, those scoring 10-points or greater on the Beck Depression
Inventory or having a previous diagnosis of depression had higher odds of developing
MetS (OR=1.67; 95% CI: 1.15-2.44).82 However, those scoring 10-points or greater on
the Beck Depression Inventory and with a previous diagnosis of depression did not
demonstrate higher odds as the confidence interval for the odds ratio crossed 1.0
(OR=1.59; 95% CI: 0.94-2.67).82 Two meta-analysis studies investigated the risk of posttraumatic stress disorder (PTSD) for developing MetS. Compared to the general
population, those with PTSD had a higher risk83 (RR=1.82; 95% CI: 1.72-1.92) and
higher odds84 (OR=1.37; 95% CI: 1.03-1.82) of developing MetS. In investigating levels
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of perceived stress, those with higher perceived stress demonstrated greater odds of
developing MetS compared to those with lower perceived stress (OR=1.45; 95% CI:
1.21-1.74).85 Occupational stress demonstrated the highest odds (OR=1.69; 95% CI:
1.18-2.42) while general perceived stress demonstrated the lowest (OR=1.22, 95% CI:
1.02-1.46).85 Anxiety has been found to increase the odds of developing MetS, however,
only marginally (OR=1.07; 95% CI=1.01-1.12).86 Ensuring patients are connected with
the proper providers to manage emotional health is an important consideration managing
a patient’s metabolic risk.
Sleep has also been demonstrated as a risk factor for the development of MetS. In
analyzing 12 cross-sectional studies, a short sleep duration (< 5 to 6 hours) increased
odds of MetS development (OR=1.27; 95% CI: 1.10-1.48). However, three pooled cohort
studies did not demonstrate greater odds as the confidence interval for the odds ratio
crossed 1.0 (OR=1.62; 95% CI: 0.74-3.55).87 Long sleep duration also was found to
increase the odds of developing MetS in 11 pooled cross-sectional studies (OR=1.23;
95% CI: 1.02-1.49). Yet again, two pooled cohort studies did not demonstrate greater
odds as the confidence interval for the odds ratio crossed 1.0 (OR=1.62; 95% CI: 0.863.04).87 Patients with obstructive sleep apnea (OSA) have also been demonstrated to have
higher odds of developing MetS with those with mild OSA (OR=2.39; 95% CI: 1.653.46) having lower odds than those with moderate-to-severe OSA (OR=3.45; 95% CI:
2.33-5.12).88 The odds of developing MetS in the presence of OSA remains significant
even when controlling for obesity (OR=1.96; 95% CI: 1.73-2.22).89 Therefore, properly
identifying and managing sleep dysfunction should be a focus in evaluating a patient’s
metabolic risk.

24

Dietary habits also can influence a patient’s metabolic risk. Those consuming a
healthy diet pattern had lower odds for developing MetS compared to those with less
healthy eating habits in pooled cross-sectional studies (OR=0.83; 95% CI: 0.76-0.90)
while pooled cohort studies (OR=0.91; 95% CI: 0.68-1.21) did not demonstrate greater
odds as the confidence interval for the odds ratio crossed 1.0.90 Those following a
Western dietary patterns had higher odds in pooled cross-sectional studies (OR=1.28; CI:
1.17-1.40) but not pooled cohort studies (OR=0.96; 95% CI: 0.53-1.73) of developing
MetS.90 Individuals in the highest quantile of sugar sweetened beverage consumption had
a 20% greater risk of developing MetS (RR=1.20; 95% CI: 1.12-1.41).91 Drinking coffee
(RR=0.87; 95% CI: 0.79-0.96) and tea (RR=0.83; 95% CI: 0.73-0.95) were associated
with lower risk of developing MetS.92 Therefore, dietary interventions can play an
important role in the management of chronic disease, highlighting the importance of
nutritional specialists as a part of the multidisciplinary team.
Interestingly, meta-analysis investigation of the risk factors for MetS have found
that they are also risk factors for the other risk factors themselves. Poor sleep increases
the risk of obesity,93,94 anxiety,95 depression,95-97 and hypertension.98,99 Physical activity
positively influences anxiety,100-104 depression,103,105-107 sleep,108 and obesity.109
Depression110 and anxiety111 increase risk of hypertension. Thus, the influence of the risk
factors of MetS, and the interplay between those risk factors, must be a consideration in
the development of MetS and its influence on musculoskeletal disease.
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Figure 2.1: Metabolic Syndrome, Musculoskeletal Disease, and Health Behaviors

Additionally, having previously discussed the impact of structural drivers,
community conditions, and access to quality healthcare on health behaviors and overall
health outcomes,3,4 socioeconomic considerations must be taken into account on the
pathway from health behaviors, to MetS, to PMP conditions.
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Figure 2.2: Metabolic Syndrome, Musculoskeletal Disease, Health Behaviors, and
Socioeconomic Variables

2.2

Modifiable Risk Factors of Persistent Musculoskeletal Pain
The risk factors for developing MetS are also found in PMP conditions per meta-

analysis. Smoking increases the odds of developing chronic low back pain (OR=1.78;
95% CI: 1.27-2.50) and disabling low back pain (OR=2.14; 95% CI: 1.11-4.13).112
Participation in leisure time physical activity was protective against frequent/chronic low
back pain in moderately active (RR=0.86; 95% CI: 0.79-0.94) and highly active
(RR=0.84; 95% CI: 0.75-0.93).113 Those who are overweight (RR=1.59; 95% CI: 1.341.89) or obese (RR=2.81; 95% CI=2.27-3.48) are at higher risk for developing chronic
back pain.114 Therefore, there is pooled evidence that smoking and being
overweight/obese are risk factors for chronic low back pain, with leisure time physical
activity protecting against the development of frequent/chronic low back pain.
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While not yet analyzed through meta-analysis, multiple prospective studies have
investigated the risk factors for PMP conditions including chronic neck and shoulder
pain,115 chronic low back pain,116 chronic musculoskeletal pain,117,118 chronic widespread
pain,119,120 and chronic arm pain.121 Similar risk factors were identified across these
conditions such as poor physical health,116,119 emotional distress,115,116,120 poor sleep,118120

and high body mass index.121

119,120

Exercise was also an important variable with

adequate exercise being protective against chronic arm and chronic musculoskeletal
pain.118,121 Therefore, there appears to be overlap between the risk factors for MetS and
PMP conditions which helps support the pathway between metabolic distress and
musculoskeletal disease.

2.3

The Need for Diagnostic Guidance for Intervention and Triage
Clinical diagnosis should impact management strategies, and diagnostic

classification systems have been introduced in attempts to guide clinical management of
patients with musculoskeletal pain complaints.12 Over time, a greater understanding of
the impact of socioeconomic factors and health behaviors on musculoskeletal disease has
resulted in the evolution of diagnostic classification systems in physical therapy.
Historically, diagnosis and classification of musculoskeletal pain attributed the
patient presentation exclusively to tissue damage. Patients often share this theoretical
framework, given that the beliefs of the healthcare provider strongly shapes the beliefs of
the patient.122,123 Patients often want to identify the problematic structure as evidence of a
legitimate medical problem as they experience difficulty communicating the magnitude
of their complaint to the provider in the absence of these findings.124-126 However,
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evidence now demonstrates that structural pathology does not always correlate with the
clinical presentation.127-130 Similarly, symptomatic improvement can occur in spite of
findings of structural pathology on diagnostic imaging remaining unchanged.131 In a
meta-analysis investigating outcomes following rotator cuff repair, it was determined that
“rotator cuff repair may not alter natural history” of the disease compared to nonoperative management132 and of the randomized control trials comparing sham surgery to
actual surgery, outcomes in pain and disability were found to be equivocal.133 Therefore,
while it is important to consider the underlying structural pathoanatomy in regards to the
patient presentation, the tissues are not the only factor to contemplate when managing
patients with PMP.
In physical therapy, new classification systems have been introduced, beginning
with movement impairments and treatment based approaches, and progressing to
neurophysiological and biopsychosocial classification systems to pain to better capture
the patient’s experience. Movement-based classification systems12 were developed to
guide treatment based on impairments observed in patient movement. Examples include
Mechanical Diagnosis Therapy12,134 and Movement Impairment Syndromes.12,135
Mechanical Diagnosis Therapy uses repeated motions to determine a directional
preference of movement that improves clinical signs and/or symptoms of the patient’s
chief complaint.134 Movement Impairment Syndromes are based in kinesiology and
biomechanics, identifying movement dysfunctions in the musculoskeletal system that
may be contributing to the clinical presentation.135 However, movement-based
classifications have also been found not to fully explain the pain experience. In a cohort
of 723 subjects with low back pain, adding Mechanical Diagnosis Therapy to a risk-
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adjusted model to predict functional outcomes did not have a significant impact.136 At
one-year follow up, Mechanical Diagnosis Therapy was found to have equivocal
outcomes in pain and disability when compared to motor control exercises in patients
with chronic low back pain.137 When compared to a group Back School program,
Mechanical Diagnosis Therapy was found to be more effective in improving disability,
but effect sizes were small.138 Similar findings have been noted in movement impairment
based classifications. Two meta-analyses have investigated biomechanical contributions
to patellofemoral joint pain. No association was found between isometric hip strength and
the development of patellofemoral joint pain.139 Lower knee extension strength was
predictive of patellofemoral joint pain, but a set of other measures, including height,
weight, leanness, Q-angle, number of sit-ups performed, and peak knee valgus during
landing were non-predictive.140 Meta-analysis found that a pronated foot posture was
predictive of developing medial tibial stress syndrome and patellofemoral pain, but effect
sizes were small.141 Pronated foot posture did not predict any other lower extremity
injury. Specifically regarding Movement Impairment Syndromes, when compared to nonspecific treatment, no differences between groups were noted.12,142 Thus, while
movement-based and biomechanical variables should be a part of clinical reasoning to
guide musculoskeletal interventions, a wider lens must be used when considering the
patient presentation.
Treatment-Based Classification systems were also introduced to help guide
clinical reasoning in managing patients with pain complaints. These systems use clinical
findings to categorize patients into groups based on the intervention to which they are
most likely to respond.12,143,144 In acute and subacute low back pain, Treatment-Based

30

Classification systems out performed non-matched treatments in improving patient
outcomes.145 However, when applied in a population with persistent low back pain,
Treatment-Based Classification systems did not impact outcomes any greater than
standard guideline-based care.12,146 In attempts to improve efficacy of Treatment-Based
Classification systems, psychosocial variables have been incorporated, particularly the
domain of fear-avoidance.12,147 Thus, pathoanatomy, movement-based classifications, and
treatment-based classifications can add value in matching the patient to the proper
intervention strategy, however, the clinician must also take into account nonmusculoskeletal findings.
In place of structural identification, classification systems have been developed
instead to identify pain by the underlying neurophysiological mechanisms.12 Smart et al
introduced a checklist to categorize patients into groups based on mechanisms of pain
mediation, including nociceptive, peripheral neuropathic, nociplastic (central
sensitization), or mixed presentations thereof.148,149 Along with pain mechanisms,
psychosocial contributions to the pain experience are also considered. While the
reliability and validity of this classification system has been studied,149-153 management
strategies and outcomes based on this subgrouping are yet to be evaluated. However,
given that the nervous systems of patients in each subgroup can be processing
nociceptive information in different ways, consideration of the neurophysiological
mechanisms of the pain experience is an important consideration for clinical reasoning.
Classification systems based on psychosocial variables have also been
presented.12 The STartBack Screening Tool154 uses a questionnaire capturing pain,
function, distress, fear, anxiety, catastrophizing, depression, and bothersomeness to
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stratify patients into low-, medium-, and high-risk subgroups. General management
recommendations are made based on these groupings, ranging from education and
reassurance, to a course of physical therapy with emphasis on cognitive, emotional, and
behavioral strategies.154 Evaluation of outcomes using this patient stratification and
management guidelines are currently being studied,155 however, meta-analysis of five
studies using the STartBack Tool has found the classification system to be “noninformative” for discriminating outcomes related to low back pain and “acceptable” for
low back disability outcomes at follow-up.156 Indeed, identification and incorporation of
musculoskeletal, neurophysiological, and psychosocial factors influencing the pain
experience can be a demanding task for the clinician.
In attempts to consolidate many different systems into one, O’Sullivan proposed a
classification system incorporating elements of the above mentioned classifications
which considers triage, time course of the disorder, neurophysiological factors, cognitive
factors, social and cultural factors, work-related factors, lifestyle factors, health and pain
comorbidities, individual factors, deconditioning, and pain communicative
behaviors.12,157,158 Based on these variables, Cognitive Functional Therapy is
recommended as management, tailoring the interventions based on the individual patient
needs. The goals of Cognitive Functional Therapy are to “provide a person-centered,
biopsychosocial understanding of pain, enhance pain coping strategies through cognitive
restructuring, stress and threat reduction, and pain control via targeted functional training
and lifestyle change.”158 Initial evaluation of Cognitive Functional Therapy in patients
with chronic low back pain found it more effective than a group-based exercise and
education intervention in reducing disability at 6- and 12-months, but no differences
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between groups for pain outcomes were found.12,159 Thus, a move towards a more
complete, systems-based approach for evaluation and management of PMP has evolved
in the profession. However, further refinement is needed to better capture the clinical
presentation to guide management of these patient populations. To be complete,
musculoskeletal impairments (movement-based and treatment-based classifications),
neural processing of pain (neurophysiological mechanism classifications), and
biopsychosocial variables (STartBack tool and O’Sullivan) should all be included in the
patient work up and subsequent management. Further research is needed to determine the
best clinical technologies to capture the domains and develop consensus in regards to
these measures so that an individualized, yet standardized, approach can be used by the
clinician to guide clinicians to improve outcomes in patients with PMP.
Similarly, in physical therapy settings working with patients with limited access
to healthcare, further guidance is needed in regards to medical triage in patients at risk for
chronic disease. Revisiting the diagnostic criteria for MetS, only blood pressure and waist
circumference are clinical measures that can be taken by the physical therapist. The
remaining criteria require blood work, which is outside the scope of practice of physical
therapy and potentially costly examinations for the uninsured populations. Thus,
identifying additional non-invasive clinical measures that can further inform the clinician
about the health status of the patient is necessary to ensure proper referrals to additional
members of the healthcare team can be made.
In summary, classification systems have moved to encompass a whole-person,
patient-centered approach by not only capturing movement impairments, but also
socioeconomic, emotional health, and physical health variables. However, while many
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instruments are available to screen for and capture these domains, further investigation of
these measures is warranted to determine which measures best inform management
strategies for patients with musculoskeletal disease.

2.4

Clinical Measurement of Risk Factors for Chronic Disease
Based on the risk factors for chronic disease, a literature search was performed to

identify impactful, clinically efficient measures to capture these risk factors of chronic
disease, morbidity, and mortality of a patient population attending a PTPBC. A
standardized physical and emotional health battery was then created to assist clinicians
and student clinicians with clinical decision making incorporating important domains
identified in the diagnostic classification systems presented above.
2.4.1

Metabolic Syndrome

As mentioned, the diagnostic criteria for MetS requires the patient to undergo
blood work to assess triglyceride, blood glucose, and high-density lipoprotein levels.30
However, non-invasive models have been developed to assess metabolic risk.
Investigating a working population, Romero-Saldaña et al found that by using a cutoff of
waist-to-height ratio (WtHR) of greater than or equal to 0.55 and a cutoff greater than or
equal to 128/85 mmHg for blood pressure was able to identify those with MetS with a
sensitivity of 91.6% and specificity of 95.7%.160 A validation of this study was performed
which updated the cutoff values to greater than or equal to 0.56 for WtHR and greater
than or equal to 128/80 mmHg for blood pressure, resulting in a sensitivity of 54.7%, a
specificity of 94.9%.161 The same author found that WtHR was the best predictor of MetS
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in a population attending a nursing practice, with a cutoff of greater than or equal to 0.54
resulting in a sensitivity of 70% and a specificity of 77%. More recently, a nomogram
was developed by Wang et al using measures of age, smoking status, body fat percentage,
waist circumference, and systolic and diastolic blood pressure to estimate the probability
of having MetS.162 Thus, researchers have begun to investigate non-invasive strategies to
capture metabolic status. However, these models still rely on physiologic measures and
may be improved by considering measures of physical function or emotional health.
2.4.2

Cardiovascular and Pulmonary Function

Along with hypertension, measures of cardiovascular and pulmonary function can
provide insight into the patient’s physical health status. Peak expiratory flow (PEF)
finrate is the measure of maximal flow rate, or speed, of a patient’s forceful expiration
measured through the use of a peak flow meter in units of liters per minute.163 Predicted
normative values can be calculated using the patient’s height, age, and
race/ethnicity.164,165 The relationship between peak expiratory flow rate and mortality has
been studied, with lower values predicting higher mortality.166-168 Another cardiovascular
indicator, aerobic capacity, or maximal oxygen uptake (VO2 max), is the measurement of
the maximum rate of oxygen consumption a patient can use during maximal exercise,
and is reflective of cardiovascular fitness.169 The American Heart Association published
a statement paper recommending that aerobic capacity be adopted as a clinical vital sign
given that lower values are associated with cardiovascular disease and all-cause
mortality,170-172 even when adjusted for potential confounders. Measuring cardiovascular
fitness in a population with persistent pain can be difficult as musculoskeletal pain often
precludes participation in more vigorous maximal or submaximal aerobic capacity
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testing. Fortunately, a non-exercise model to predict aerobic fitness has been developed.
This equation estimates VO2max using the patient’s age, waist circumference, resting
heart rate, and physical activity index.173 This model has been shown to explain 61% and
56% of the variance in measured VO2max in men and women, respectively.173 Thus,
measuring peak expiratory flow using a peak flow meter and calculating predicted
aerobic capacity using a non-exercise model are accessible tests for the patient and
clinician to better inform health status.
2.4.3

Musculoskeletal Function

Measures of musculoskeletal function have also been associated with chronic
disease, morbidity, and mortality. Grip strength using hand dynamometry has been
associated with all-cause, cardiovascular, and non-cardiovascular mortality and was a
stronger predictor than systolic blood pressure in both all-cause and cardiovascular
mortality.174,175 In older adults, men with lower grip strength had mortality rates 64-74%
higher at 10-years and women with lower grip strength had 48% higher mortality
rates.174,176 The Center for Disease Control and Prevention recommends the use of the 30second sit-to-stand test, measured in number of reps performed in 30-seconds, as a screen
for fall risk.177 In adults aged 60-64, a score less than 14 repetitions for males and 12
repetitions for females increases fall risk.178 While normative values for the 30-second
sit-to-stand in adults under the age 60 are limited, it is logical to assume that these
populations should function at least as well as the older cohort. Falls are an important
consideration for mortality, as 29,668 residents in the United States over the age of 65
died as a result of a fall in 2016.179 Last, walk tests, measuring distance completed in a set
time frame, have been studied in relationship to morbidity and mortality. Low scores on
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the six-minute walk test have been associated with all-cause mortality, coronary heart
disease specific mortality, and incident coronary heart disease.180 Compared to the sixminute walk test, the two-minute walk test has been demonstrated to be as reliable and
valid

181,

making it a more efficient clinical test. Thus, grip strength, the 30-second sit-to-

stand test, and the two-minute walk test can be important and efficient measures in
capturing disease.
2.4.4

Sleep

As previously discussed, sleep is a risk factor for both MetS and musculoskeletal
pain conditions. Clinically, questionnaires can be used to screen a patient’s sleep quality.
The Pittsburgh Sleep Quality Index (PSQI) is a 19-item questionnaire which is further
broken down into seven component scores that are totaled.182 Scoring higher than five on
the PSQI was found to be fairly good at identifying patients with a sleep disorder,
demonstrating a sensitivity of 89.6% and specificity of 86.5%.182 Another validated
instrument for assessing sleep is the Insomnia Severity Scale (ISS).183 This scale totals
the responses to seven items and a cutoff score of 10 identified patients with a sleep
disorder at a sensitivity of 86.1% and a specificity of 87.7%.183 Both questionnaires
appear to be valid for screening purposes, however, there is some evidence to support the
ISS as a better option to track improvement in sleep quality.184 Additionally, not all sleep
quality is related to insomnia. The STOP BANG is an eight-item screening tool that uses
subjective questions about snoring, feeling tired, observation of dysfunctional breathing
during sleep, and having hypertension, along with body mass index, age, neck
circumference, and gender variables to determine risk of obstructive sleep apnea
(OSA).185,186 This screening tool has demonstrated validity, with predicted probability of
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OSA increasing from 0.36 to 0.60 when comparing a score of three to a score of seven or
eight.185,186 Thus, relatively short questionnaires and tools can be used to screen for sleep
dysfunction in a patient population.
2.4.5

Emotional Health Measures

As described previously, depression, PTSD, perceived stress, and to a lesser
extent, anxiety are important risk factors to consider for chronic disease and pain. The
Patient Health Questionnaire (PHQ-4) is a four-item, brief screening tool validated to
identify patients with anxiety and depression.187 A score of three or more on the
depression or anxiety subscales suggest the presence of a disorder and referral to a mental
health professional should be considered.187 The Posttraumatic Stress Disorder (PTSD)
Checklist for DSM-5 (PCL-5) has been psychometrically validated to measure symptoms
of PTSD.188 A score of 33 or greater on this 20-item questionnaire would warrant referral
to a mental health provider for further diagnosis and management of PTSD.189 The
Primary Care PTSD Screen for DSM-5 (PC-PTSD-5) has also been developed and
validated to identify patients with signs and symptoms consistent with PTSD.190 This
questionnaire was developed to be only five items to increase clinical efficiency, with a
score of three or higher indication potential PTSD.190 Perceived stress can be captured
through use of the Perceived Stress Scale-4 (PSS-4).191 This validated measure has
patients rate four questions regarding the frequency of feelings and thoughts related to
stress on a 5-point Likert scale ranging from “0” (Never) to “4” (Very often). Higher
scores are correlated to higher levels of perceived stress.191 Therefore, the PHQ-4, PCPTSD-5, and the PSS-4 can be used to capture multiple emotional health domains
without significant administrative burden.
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2.4.6

Socioeconomic Measures

As noted previously, factors such as race/ethnicity, income, proximity to food
sources, and education levels influence health outcomes. Along with demographic
questions regarding these variables, the construct of self-efficacy can be a helpful
indicator of health outcomes in chronic disease.192,193 Perceived self-efficacy is
representative of an “individual’s beliefs in their capabilities to exercise control over a
particular task and their own functioning, and…optimistic beliefs about one’s capability
to cope with barriers that arise during the period of behavioral maintenance.”194,195
General self-efficacy can also be captured through questionnaire format. A six-item short
form of the General Self-Efficacy Scale (GSES-6) has been validated for use.196,197 This
questionnaire has the patient rate statements about self-efficacy on a four-point Likert
scale ranging from “1” (not at all true) to “4” (exactly true). Higher scores are reflective
of higher self-efficacy. In patients with PMP, meta-analysis has found self-efficacy to be
an extremely important predictor of outcome, with low levels of self-efficacy predicting
poorer outcomes.198 Specific to pain, a two-item Pain Self-Efficacy Questionnaire
(PSEQ-2) has been validated.199 This questionnaire has the patient rate their confidence
in performing certain tasks despite their pain on a 7-point Likert scale ranging from “0”
(not at all confident) to “6” (extremely confident). Higher scores represent higher pain
self-efficacy.199 In subjects with persistent pain, improving pain self-efficacy has been
demonstrated to be associated with a reduction in disability, independent of changes in
pain levels.200 Along with demographic variables related to socioeconomic status,
capturing measures of perceived self-efficacy can improve the clinician’s understanding
of the patient presentation.
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2.5

Summary
In summary, chronic disease and PMP conditions are significant issues affecting a

large portion of the population resulting in immense societal costs. While diagnostic
classification systems have been developed for musculoskeletal pain, further research is
needed to better identify the measures that should be used to capture this population so
that results are meaningful for the clinician. These measures should not only capture
musculoskeletal function, but also emotional health and socioeconomic variables know to
contribute to health outcomes, as minority populations with lower income and education
levels are more greatly impacted by chronic disease. Similarly, it will be important for the
identified measures to be clinically efficient so that the burden of incorporating these
tests does not prohibit their use in the clinical setting. Also, given the interplay between
the risk factors for chronic disease and PMP conditions, it is important to study the
relationships between these variables to determine which moderate outcomes and which
ones mediate outcomes. Similarly, it is important to identify novel patient subgroups
based on these risk factors to allow for more targeted assessment of the patient
population, allowing for more effective and efficient intervention strategies.
The purpose of this study is to assess a clinical population of patients presenting
to a pro bono physical therapy clinic with complaints of musculoskeletal pain. The
primary aims of this study are:
1) To describe the population based on physical health, emotional health, and
socioeconomic variables.
a. This will determine the needs of this population to inform future
interdisciplinary care and advocacy endeavors.
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2) To investigate the association between physical health (BMI, systolic blood
pressure, diastolic blood pressure, mean arterial pressure, resting heart rate, waist
circumference, WtHR, peak expiratory flow rate, predicted VO2max, grip
strength, 30-second sit-to-stand, fall risk, 2-minute walk test, gait speed, smoking
status), emotional health (PHQ-4 anxiety, PHQ-4 depression, PSS-4, ISS, GSES6, PSEQ-2), and socioeconomic (age, sex, employment status, highest level of
education, race/ethnicity, food insecurity) variables to group membership of those
at risk of MetS versus those without.
a. This will inform potential targets for clinical measures that can be
incorporated into a non-invasive testing battery to diagnose patients with
MetS.
3) To investigate differences between those “at-risk” of MetS and those not at risk of
MetS in the domains of pain (chronicity, severity, number of descriptors chosen),
socioeconomic (level of education, employment status, race/ethnicity, smoking
status, food insecurity), psychosocial (PSS-4, PHQ-4 anxiety, PHQ-4 depression,
ISS, GSES-6), and physical health performance (number of medications taken,
predicted VO2max, two-minute walk test, 30-second sit-to-stand test, peak
expiratory flow rate, grip strength).
a. This will help determine if those with MetS have a uniquely different
clinical presentation that may inform modification to clinical management
strategies
4) To identify novel subgroups of patients based on measures of the pain experience,
physical health, and emotional health variables.
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a. This will inform a more targeted approach in measurement and treatment
of these patient populations.
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CHAPTER 3. METHODS
3.1

Study Design
Based on the extensive background literature presented in Chapter Two, the

author developed a standardized intake packet and physical health testing battery to be
completed by all patients a PTPBC at initial visit. The tests and measures were chosen
based on perceived clinically usefulness, ability to provide insight into the patient’s pain
experience, and the opportunity for discussion about the role of health behaviors with this
patient population; thus, shifting the belief model from pathoanatomy to a whole-systems
approach. Given the clinical nature and standard of care of the intake and physical health
batteries, all information regarding these measures were documented in the initial
evaluation through electronic medical records. At the initial sessions, patients were to
arrive 30-minutes prior to their scheduled visit to complete the intake packet in the
waiting room administered by the front desk staff. The intake paperwork contained
questions relating to demographics, the reason for the visit, pain description and nature,
associated symptoms, history of care, food insecurity, exercise participation, medical
history, current medications, pain self-efficacy, stress, anxiety, depression, suicidal
ideation, post-traumatic stress, sleep, general self-efficacy, health literacy, and fall risk.
Physical measures of health were captured during the initial evaluation, performed by the
treating physical therapist or Doctor of Physical Therapy students under the observation
of a licensed physical therapist. Thus, the data used in this study were accessed through
retrospective chart review. The PTPBC initial intake packet and data collection sheet can
be found in the Appendix.

3.2

Sample
Data from the initial evaluation of all patients attending the PTPBC was

retrospectively reviewed and collected from a two-year period representing December
2017 through December 2019. Patients under the age of 18 years and those missing a
substantial amount of information collected at the initial evaluation were excluded from
the data collection. Given the clinical nature of this study, reasons for missing
information included language barriers preventing completion of intake paperwork,
patients not thoroughly completing initial paperwork, error/omission of tests and
measures when training entry level students in the clinical setting, and/or late patient
arrival to the initial visit precluding the ability to perform certain tests and measures
during the first session. In total, data were collected from 504 patient charts.

3.3

Data Collection
Prior to the data collection process, approval for the study was obtained from the

High Point University Internal Review Board (IRB). The following describes the
information and measures collected during the retrospective chart review:
3.3.1

Metabolic Syndrome Risk

Using the model described by Romero-Saldaña et al161, risk of MetS was
determined using a cut-off for WtHR greater than or equal to 0.56 and blood pressure
greater than or equal to 128/80 mmHg. Those exceeding these cut-off scores were
classified as at risk for MetS while those falling below the cut-off were classified as not
at risk. Thus, this information was inputted dichotomously.
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Table 3.1: Criteria for MetS Risk
Blood pressure ≥ 128/80 mmHg

Yes to both: ____ (positive for risk)

Waist-to-height ratio ≥ 0.56

Yes to ≤ 1: ____ (negative for risk)

3.3.2

Cardiovascular and Pulmonary Function

Blood pressure readings were captured as continuous data for systolic (SBP) and
diastolic (DBP) values which were then used to calculate mean arterial pressure
(MAP).201 Blood pressure values were also categorized for each patient into “normal”,
“prehypertensive”, “stage I hypertension”, “stage II hypertension”, and “hypertensive
crisis” as outlined by the American Heart Association.202 Categorization of MAP was
performed using a cut-off of greater than 100 mmHg to identify dichotomous groups of
those with hypertension versus those without.201,203,204

Table 3.2: Blood Pressure Categories
Category

Systolic

Diastolic

Normal

< 120

< 80

Prehypertension

120 – 129

< 80

Stage I hypertension

130 – 139

80 – 90

Stage II hypertension

> 140

> 90

Hypertensive crisis

> 180

> 120

Cardiovascular and pulmonary function was additionally assessed using values
recorded from peak expiratory flow rate testing and prediction of maximal oxygen update
(VO2max). Raw scores for peak expiratory flow rate were captured as continuous data in
L/min. To categorize peak expiratory flow rate results, predicted values based age,
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height, and race/ethnicity were calculated and those scoring 80% or greater of the
predicted score were classified as normal, 50-79.9% were classified as low, and 0-49.9%
were classified as very low.164,165,205

Table 3.3: Peak Expiratory Flow (L/min) Equations
Age
≥ 18 years

Sex
Female

Race/ethnicity
Black/AfricanAmerican

Equation
60 [1.3597 + 0.03458 (age) –
0.000847 (age)2 + 0.00019746
(height, cm)2]
White/non-Hispanic
60 [0.9267 + 0.06929 (age) –
0.001031 (age)2 + 0.00018623
(height, cm)2]
Latino/Latinx
60 [0.2401 + 0.06174 (age) –
0.001023 (age)2 + 0.00022203
(height, cm)2]
Other
{[(height, m × 3.72) + 2.24] - [Age ×
0.03]} × 60
≥ 20 years Male
Black/African60 [2.2257 – 0.04082 (age) +
American
0.00027333 (height, cm)2]
White/non-Hispanic
60 [1.0523 + 0.08272 (age) –
0.001301 (age)2 + 0.00024962
(height, cm)2]
Latino/Latinx
60 [0.0870 + 0.06580 (age) –
0.001195 (age)2 + 0.00030243
(height, cm)2]
Other
{[(height, m × 5.48) + 1.58] - [age ×
0.041]} × 60
Peak flow variability
(measured PEF / estimated PEF) x 100
> 80%
Green (normal)
50-80%
Yellow (low)
< 50%
Red (very low)
Predicted maximal oxygen uptake (VO2max) was calculated using the nonexercise model described by Nes at al.173
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Table 3.4: Non-exercise Model to Predict VO2max
Sex
Female

Predicted VO2max equation
74.74 – (0.0.247 x age) – (0.259 x waist circumference) – (0.114 x resting
heart rate) + (0.198 x physical activity index)

Male

100.27 – (0.296 x age) – (0.369 x waist circumference) – (0.155 x resting
heart rate) + (0.226 x physical activity index)
Physical activity index
Responses
Index value
“How frequently do you exercise?”
Never/less than once a week
0
Once a week
1
Two to three times a week
2
Almost every day
3
“How hard do you push yourself?”

Take it easy
Heavy breath and sweat
Push near exhaustion

0
5
10

“How long does each session last?”

Less than 30 minutes
Greater than 30 minutes

1
1.5

Raw scores were captured as continuous data in ml/kg/min. Once the predicted
value was determined, it was categorized as “very poor”, “poor”, “fair”, “good”,
“excellent”, or “superior” based on the values described by the Cooper Institute of
Aerobics Research for each category based on age and sex of the participant.169

Table 3.5: VO2max Categories for Females (values in ml/kg/min)
Age
13 – 19

Very poor
< 25.0

Poor
25.0 - 30.9

Fair
31.0 - 34.9

Good
35.0 - 38.9

Excellent
39.0 - 41.9

Superior
> 41.9

20 – 29

< 23.6

23.6 - 28.9

29.0 - 32.9

33.0 - 36.9

37.0 - 41.0

> 41.0

30 – 39

< 22.8

22.8 - 26.9

27.0 - 31.4

31.5 - 35.6

35.7 - 40.0

> 40.0

40 – 49

< 21.0

21.0 - 24.4

24.5 - 28.9

29.0 - 32.8

32.9 - 36.9

> 36.9

50 – 59

< 20.2

20.2 - 22.7

22.8 - 26.9

27.0 - 31.4

31.5 - 35.7

> 35.7

60 +

< 17.5

17.5 - 20.1

20.2 - 24.4

24.5 - 30.2

30.3 - 31.4

> 31.4
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Table 3.6: VO2max Categories for Males (values in ml/kg/min)
Age
13 – 19

Very poor
< 35.0

Poor
35.0 - 38.3

Fair
38.4 - 45.1

Good
45.2 - 50.9

Excellent
51.0 - 55.9

Superior
> 55.9

20 – 29

< 33.0

33.0 - 36.4

36.5 - 42.4

42.5 - 46.4

46.5 - 52.4

> 52.4

30 – 39

< 31.5

31.5 - 35.4

35.5 - 40.9

41.0 - 44.9

45.0 - 49.4

> 49.4

40 – 49

< 30.2

30.2 - 33.5

33.6 - 38.9

39.0 - 43.7

43.8 - 48.0

> 48.0

50 – 59

< 26.1

26.1 - 30.9

31.0 - 35.7

35.8 - 40.9

41.0 - 45.3

> 45.3

60 +

< 20.5

20.5 - 26.0

26.1 - 32.2

32.3 - 36.4

36.5 - 44.2

> 44.2

3.3.3

Musculoskeletal Function

Measures of musculoskeletal function included grip strength, the 30-second sit-tostand test, and the two-minute walk test. Grip strength was tested on both right and left
sides using a JAMAR hand dynamometer (Patterson Medical, Warrensville, IL). Testing
was completed in a sitting position with the tested arm at the patient’s side, elbow bent to
90 degrees, and cueing to give a maximal effort throughout the test, using the second
handle position to be consistent with procedures used during development of normative
values.206-208 Raw scores were captured as continuous data in kilograms. Results were
categorized based on normative values by age and sex, with “normal” values representing
a score within one standard deviation above or below the mean, “low” falling greater than
one standard deviation below the mean, and “high” falling greater than one standard
deviation above the mean.
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Table 3.7: Normative Values for Grip Strength (in kg)

Low
< 48.2

Men
Normal
48.2 – 65.45

High
> 65.45

< 39.9

39.9 – 57.85

> 57.85

< 45.2

45.2 – 63.35

> 63.35

< 42.6

42.6 – 56.7

> 56.7

< 43.6

43.6 – 66.35

> 66.35

< 39.65

39.65 – 58.05

> 58.05

< 44.45

44.45 – 67.2

> 67.2

< 42.25

42.25 – 61.35

> 61.35

< 45.65

45.65 – 64.05

> 64.05

< 42.25

42.25 – 61.35

> 61.35

< 39.75

39.75 – 60.25

> 60.25

< 35.85

35.85 – 59.25

> 59.25

< 43.75

43.75 – 60.1

> 60.1

< 39.05

39.05 – 55.65

> 55.65

< 36.4

36.4 – 58.0

> 58.0

< 28.65

28.65 – 48.3

> 48.3

< 32.0

32.0 – 51.55

> 51.55

< 23.6

23.6 – 43.8

> 43.8

< 33.45

33.45 – 50.45

> 50.45

< 27.2

27.2 – 44.05

> 44.05

Age
20-24

Hand
R

Low
< 26.45

Women
Normal
26.45 – 37.6

L

< 21.35

21.35 – 33.85

> 33.85

R

< 27.85

27.85 – 39.0

> 39.0

L

< 25.35

25.35 – 36.5

> 36.5

R

< 28.35

28.35 – 49.05

> 49.05

L

< 23.65

23.65 – 41.6

> 41.6

R

< 28.2

28.2 – 39.35

> 39.35

L

< 26.2

26.2 – 35.75

> 35.75

R

< 24.65

24.65 – 39.4

> 39.4

L

< 22.1

22.1 – 35.5

> 35.5

R

< 23.0

23.0 – 36.9

> 36.9

L

< 21.15

21.15 – 31.6

> 31.6

R

< 23.6

23.6 – 34.7

> 34.7

L

< 20.95

20.95 – 30.25

> 30.25

R

< 20.5

20.5 – 32.55

> 32.55

L

< 17.8

17.8 – 28.0

> 28.0

R

< 20.9

20.9 – 30.0

> 30.0

L

< 17.0

17.0 – 25.4

> 25.4

R

< 19.2

19.2 – 28.05

> 28.05

L

< 15.9

15.9 – 23.6

> 23.6

25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65-69
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High
> 37.6

Table 3.7 (continued): Normative Values for Grip Strength (in kg)
Low
< 24.35

Men
Normal
24.35 – 41.65

High
> 41.65

< 22.0

22.0 – 35.9

> 35.9

< 24.05

24.05 – 45.65

> 45.65

< 19.55

19.55 – 39.55

> 39.55

Age
70-74

Hand
R

Low
< 18.75

Women
Normal
18.75 – 29.0

High
> 29.0

L

< 14.7

14.7 – 24.7

> 24.7

R

< 15.4

15.4 – 24.45

> 24.45

L

< 14.0

14.0 – 22.4

> 22.4

75+

The 30-second sit-to-stand test requires the patient to stand from a seat 17-inches
in height as many times as possible in 30-seconds without use of the upper extremities. A
repetition is counted each time the patient stands from the chair and if the patient is
halfway to a standing position when 30-seconds expire, this repetition is also counted.177
This this has been used to identify fall risk in older populations, with a cut-off of less than
14 repetitions for males and 12 repetitions for females aged 60-64 representing increased
fall risk.178 Thus, if a patient below the age of 60-64 scored below these cut-off values,
they were also categorized as a fall risk. Those patients aged over 60-years were
categorized based on the established cut-off scores for their sex and age group. This data
was inputted dichotomously as positive for fall risk or negative for fall risk. Raw scores
were also captured as continuous data as number of repetitions completed.
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Table 3.8: 30-second Sit-to-Stand Test Cut-off Values for Fall Risk
Age

Female

Male

60 – 64

< 12

< 14

65 – 69

< 11

< 12

70 – 74

< 10

< 12

75 – 79

< 10

< 11

80 – 84

<9

< 10

85 – 89

<8

<8

90 – 94

<4

<7

Additionally, fall risk was determined using the three screening questions
recommended by the Center for Disease Control and Prevention Stopping Elderly
Accidents, Deaths, and Injuries (STEADI) program which includes, (1) “Do you feel
unsteady when standing or walking?”, (2) “Do you worry about falling?”, and (3) Have
you fallen in the past year?”177 A positive response to any of the three questions indicates
fall risk and this data was inputted dichotomously as positive or negative for fall risk.

Table 3.9: Screening Questions for Fall Risk
“Do you feel unsteady when standing or

Yes to any item: ____ (positive fall risk)

walking?”
“Do you worry about falling?”
No to all items: ____ (negative fall risk)

“Have you fallen in the past year?”

The two-minute walk test measures the distance a patient can ambulate over the
course of two-minutes using a self-selected walking speed. Pooled data has been
analyzed to report normative values based on age and sex for this test.209 Raw scores
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were captured as continuous data in meters completed in two-minutes as well as gait
speed in m/second. Using these values, patients were categorized as “normal” if they
scored within the 95% confidence interval for the mean score in their age/sex group.
“Low” scores represented those falling below this confidence interval and “high”
represented those falling above the confidence interval. Gait speed was calculated by
taking the distance walked in meters and dividing by the time in seconds. This raw score
was inputted as continuous data. A cut-off score of 0.8 m/sec210,211 was used to
dichotomously group the population as having the gait speed necessary to ambulate in the
community compared to those with gait speeds below community ambulation.

Table 3.10: Normative Values for Two-Minute Walk Test (m)

Normal
207.2 – 228.6

Men
Low
< 207.2

Age
20 – 29

Women
Normal
Low
177.7 – 210.5 < 177.7

High
> 228.6

High
> 210.5

196.3 – 207.9

< 196.3

> 207.9

30 – 39

178.1 – 184.8

< 178.1

> 184.8

186.8 – 197.5

< 186.8

> 197.5

40 – 49

160.3 – 201.0

< 160.3

> 201.0

184.7 – 194.9

< 184.7

> 194.9

50 – 59

149.6 – 188.7

< 149.6

> 188.7

169.3 – 196.8

< 169.3

> 196.8

60 – 69

150.0 – 177.3

< 150.0

> 177.3

152.7 – 173.5

< 152.7

> 173.5

70 – 79

147.7 – 152.9

< 147.7

> 152.9
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3.3.4

Sleep and Emotional Health

Sleep quality was quantified using the ISS.183 This seven-item questionnaire uses
a five-point Likert scale (0 to 4) for each item with the responses indicating poor sleep
quality representing the higher scores.183 Thus, the overall score ranges from 0 to 28
points with higher scores reflecting poor sleep quality. This raw score was inputted as
continuous data. A cut-off of 10 points or greater was used to dichotomously group those
with potential sleep disturbance versus those without.183

Table 3.11: Insomnia Severity Scale
Please rate your current
(i.e. last two weeks)
quality of sleep
Difficulty falling asleep

None

Mild

Moderate

Severe

Very
severe

[ ]

[ ]

[ ]

[ ]

[ ]

Difficulty staying asleep

[ ]

[ ]

[ ]

[ ]

[ ]

Problems waking up too
early

[ ]

[ ]

[ ]

[ ]

[ ]

Very
satisfied

Satisfied

Moderately
satisfied

Dissatisfied

Very
dissatisfied

[ ]

[ ]

[ ]

[ ]

[ ]

Not at all
noticeable

A little

Somewhat

Much

Very much
noticeable

[ ]

[ ]

[ ]

[ ]

[ ]

How satisfied/dissatisfied
are you with your current
sleep pattern?

How noticeable to others
do you think your sleep
problem is in terms of
impairing your quality of
life?
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Table 3.11 (continued): Insomnia Severity Scale

How worried/distressed
are you about your
current sleep problem?

To what extent do you
consider your sleep
problem to interfere
with your daily
functioning (i.e. daytime
fatigue, mood, ability to
function at work/daily
chores, concentration,
memory, etc.)?

Not at all
worried

A little

Somewhat

Much

Very much
worried

[ ]

[ ]

[ ]

[ ]

[ ]

Not at all
interfering

A little

Somewhat

Much

Very much
interfering

[ ]

[ ]

[ ]

[ ]

[ ]

Obstructive sleep apnea risk was assessed using the STOP BANG
questionnaire.185 This eight-item screening tool uses subjective questions about snoring,
feeling tired, observation of dysfunctional breathing during sleep, and having
hypertension, along with body mass index, age, neck circumference, and sex to determine
risk of OSA.185 186 Results are categorized into “low” (0-2), “intermediate” (3-4), and
“high” (≥ 5) risk for OSA.
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Table 3.12: STOP BANG Questionnaire

[
[
[
[
[
[
[
[

Criteria
] Snore loudly (heard through a closed door
] Feel tired, fatigued, or sleepy during the day
] Observed stopped breathing during sleep
] Have high blood pressure
] Body mass index ≥ 35
] 50 years or older
] Neck circumference ≥ 41 cm
] Male

Risk scoring

High
Intermediate
Low

≥5
3–4
0–2

Presence of potential anxiety or depression was captured using the PHQ-4.187 This
four-item tool contains two-items related to anxiety and two-items related to depression.
Each item is scored on a four-point Likert scale (0 to 3), and a score of three or greater on
the anxiety or depression subscale suggests the potential of a diagnosis of anxiety or
depression.187 Raw scores for each subscale were captured as continuous data. This data
was also inputted dichotomously for both anxiety and depression as positive or negative
for the potential presence of these emotional health conditions.

Table 3.13: Patient Health Questionnaire – 4
Over the past 2 weeks, have you
been bothered by these problems?
Feeling nervous, anxious, or on
the edge
Not being able to stop/control
worrying
Feeling down, depressed, or
hopeless
Little interest or pleasure in doing
things

[ ]

Almost
never
[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

Never
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[ ]

Fairly
often
[ ]

Nearly
every day
[ ]

Sometimes

Perceived stress was collected using the PSS-4.191 This validated measure has
patients rate four questions regarding the frequency of feelings and thoughts related to
stress on a 5-point Likert scale ranging from “0” (Never) to “4” (Very often). Higher
scores are correlated to higher levels of perceived stress.191 This data was entered
continuously. Dichotomous grouping was performed after determining the median value
of the sample, with those scoring higher than the median being categorized as high stress.

Table 3.14: Perceived Stress Scale – 4
Please choose the best answer – In
the past month:
How often have you felt that you
were unable to control the important
things in your life?
*How often have you felt confident
about your ability to handle your
personal problems?
*How often have you felt that things
were going your way?
How often have you felt difficulties
were piling up so high that you could
not overcome them?
* items are reversed scored

Never

Almost
never

Sometimes

Fairly
often

Very
often

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

Presence of potential PTSD was captured using the PC-PTSD-5. Of the five
items, a score of three or higher was recorded as positive for the potential presence of
PTSD.190
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Table 3.15: The Primary Care PTSD Screen for DSM-5
Have you experienced a traumatic event (serious accident; fire;
disaster such as hurricane, tornado, or earthquake; physical or
sexual abuse; war; homicide; or suicide)?
If yes, in the past month, have you:
Have had nightmares about it or thought about it when you did not
want to?
Tried hard not to think about it or went out of your way to avoid
situations that reminded you of it?
Were constantly on guard, watchful, or easily startled?
Felt numb or detached from others, activities, or your
surroundings?
Felt guilty or unable to stop blaming yourself or others for the
event(s) or any problems the event(s) may have caused?

3.3.5

Yes [ ]

No [ ]

Yes [ ]

No [ ]

Yes [ ]

No [ ]

Yes [ ]

No [ ]

Yes [ ]

No [ ]

Yes [ ]

No [ ]

Self-Efficacy

Pain self-efficacy was captured using the PSEQ-2.199 Using a seven-point Likert
scale (0 to 6) for each item a total score of 0 to 12 is calculated with lower scores
representing lower pain self-efficacy.199
Table 3.16: Pain Self-Efficacy Questionnaire 2-Item
Please rate how confident you are that you can
do the following things at present:
I can do some form of work, despite the pain
(“work” includes housework and paid/unpaid
work).
I can live a normal lifestyle, despite the pain.

Not at all confident
0
1
2
3

4

Confident
5
6

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

Similarly, general self-efficacy was captured using the GSES-6 which uses a fourpoint Likert scale (1 to 4) for each item to calculate a total score of 4 to 24, with lower
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scores representing lower general self-efficacy.196,197 Both PSEQ-4 and GSES-6 measures
were inputted as continuous data. Dichotomous grouping was performed after
determining the median value of the sample. Those scoring lower than the median value
on the PSEQ-4 were categorized as low pain self-efficacy, and those scoring lower than
the median value on the GSES-6 were categorized as low general self-efficacy.

Table 3.17: General Self-Efficacy Scale 6-Item
Please select the best answer:
- If someone opposes me, I can find means
and ways to get what I want.
- It is easy for me to stick to my aims and
accomplish my goals.
- I am confident that I could deal
efficiently with unexpected events.
- Thanks to my resourcefulness, I know
how to handle unforeseen situations.
- I can remain calm when facing
difficulties because I can rely on my
coping abilities.
- No matter what comes my way, I’m
usually able to handle it.
3.3.6

Not at
all true

Hardly
true

Moderately Exactly
true
true

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

Socioeconomic Variables

The intake paperwork at the PTBPC captured variables related to socioeconomic
status including age, sex, employment status, highest level of education achieved,
race/ethnicity, and food insecurity. Age was inputted as continuous data. Sex and food
insecurity were dichotomous variables entered as male or female, or, reporting yes or no
for presence of food insecurity. Food insecurity was assessed using a 1-item screening
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tool, “Have there been times in the last 12 months when you and your family did not have
the food you needed or the resources necessary to purchase food?”, modified from the 2item screening tool for food insecurity.212 Employment status (yes/full-time, yes/parttime, no/unemployed, no/disabled, no/retired), highest level of education (did not
complete high school, high school/GED, some college, Bachelor’s or technical degree,
some post-graduate, Master’s degree, advanced academic or clinical graduate degree),
smoking (yes, no) and race/ethnicity (Black/African-American, White/non-Hispanic,
Latino/Latinx, Asian, Black/African, Native American/Indigenous, Black/Latin
American/Caribbean, Middle Eastern, Pacific Island, Multiracial/Other, Refused to
answer) were entered categorically.
Table 3.18: Socioeconomic Variables
Age
Response:
Sex
[ ] Female
[ ] Male
[ ] Other
Food insecurity
Have there been times in the last 12 months when
you and your family did not have the food you
needed or the resources necessary to purchase
food?
[ ] Yes
[ ] No
Are you presently employed?
[ ] Yes
[ ] Full-time
[ ] Part-time
[ ] No
[ ] Unemployed
[ ] Disabled
[ ] Retired
Highest level of education
[ ] Did not complete
[ ] Bachelor’s or
high school
technical degree
[ ] High school/GED [ ] Some postgraduate
[ ] Some college
[ ] Advanced academic or
clinical graduate degree
What do you consider your race? Response:
What do you consider your
Response:
ethnicity?
Do you currently smoke?
[ ] Yes
[ ] No
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3.3.7

Pain Measures

Various domains of the pain experience were captured. Usual pain intensity was
measured using a numerical pain rating scale from 0 to 20.213 Pain chronicity was
reported in number of years. Usual pain intensity and chronicity in years was inputted as
continuous data. If the patient reported constant pain, this was inputted dichotomously as
a yes or no response.

Table 3.19: Pain Intensity, Chronicity, and Constancy
What is the usual severity of your pain? (Circle the appropriate number)
No pain
Extreme pain
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
When did this problem begin?
How long does the pain typically last?
Response:
[ ] Less than 1-minute
[ ] 6-12 hours
[ ] 1-10 minutes
[ ] 13-24 hours
[ ] Less than 1-hour
[ ] Several days
[ ] 1-5 hours
[ ] Constant
Pain location was quantified in two manners. As patients often presented with
more than one area of pain complaint, region of complaint was broken up into quadrants
for the extremities and the axial skeleton/head. Thus, 18 different categories for pain
location were created ranging from no specific pain complaint to pain in all four
quadrants and the axial skeleton. This data was inputted categorically.
Generalized/widespread pain versus regional pain was determined by the report of pain in
four of these five body regions.214,215 and was inputted dichotomously as yes or no for the
presence of generalized/widespread pain.
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Figure 3.1: Body Diagram
Table 3.20: Pain Location

Wide-spread

Regional

One area of complaint
Two areas of
complaint
Three areas of
complaint

Four areas of
complaint

Five areas of
complaint

[ ] Axial
[ ] One LE
[ ] Both LE
[ ] Axial + One LE
[ ] One UE + One LE
[ ] Axial + Both LE
[ ] One LE + Both UE
[ ]Axial + One LE + One
UE
[ ] Axial + One LE + Both
UE
[ ]Axial + One UE + Both
LE
[ ] Axial + Both LE + Both
UE

[ ] One UE
[ ] Both UE
[ ] Axial + One UE
[ ] Axial + Both UE
[ ] One UE + Both LE

[ ] Both LE + Both UE

The validated Short-Form McGill Pain Questionnaire has the patient select from
15 pain descriptors that best represents their pain experience.216,217 Of these, 11 words
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relate to sensory description of pain (throbbing, shooting, stabbing, sharp, cramping,
gnawing, hot/burning, aching, heavy, tender, splitting), and four words capture the
emotional-affective component of pain (tiring/exhausting, sickening, fearful,
punishing/cruel).216,217 The emotional-affective descriptors, along with total number of
words chosen, are of particular interest as they represent a greater pain experience.216 217
Data was inputted dichotomously to demonstrate whether the patient did or did not select
one or more of the emotional-affective descriptor. Total number of words chosen was
inputted as continuous data. Dichotomous grouping was performed after determining the
median value of the sample, with those scoring higher than the median value being
categorized as selecting more pain descriptors.

Table 3.21: Short-Form McGill Pain Questionnaire Descriptors
Describe the way your pain typically feels: (please select all that apply)
[ ] Throbbing
[ ] Gnawing
[ ] Hot/burning
[ ] Tiring/exhausting*
[ ] Sickening*
[ ] Sharp
[ ] Cramping
[ ] Tender
* Indicates emotional-affective descriptors
3.4

[
[
[
[

] Splitting
] Stabbing
] Heavy
] Punishing/cruel*

[
[
[
[

] Shooting
] Aching
] Fearful*
] Other:

Data Analysis
Descriptive information (frequencies, means, and standard deviations) were used

to determine the MetS risk, cardiovascular and pulmonary function, musculoskeletal
function, sleep, emotional health, self-efficacy, and socioeconomic profile of the sample.
For regression analysis, approximately 500 adult outpatients ranging from 18-86
years of age were studied at the PTPBC. Out of these 500 subjects, 421 subjects had their
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sex, height, weight, age, and BMI reported. These 421 subjects were the initial data set
that was used for further analyses. Ultimately a data set of 412 subjects were used to
answer the main research questions.
Binary logistic regression was conducted to determine which independent
continuous variables [sex, age, weight, height, BMI, waist circumference, blood pressure
(SBP, DBP, MAP) hand grip strength, peak expiratory flow rate (L/min), predicted
VO2max (mL/kg/min), number of sit-to-stand-reps in 30-seconds, distance walked in
two-minutes, fall risk status, PHQ-4 anxiety score, PHQ-4 depression score, PSS-4 score,
ISS score, and GSES-6 score] were predictors of MetS risk (dichotomous variable). The
forward stepwise selection method enters predictors based on the score statistic and then
assess removal based on the likelihood-ratio statistic (based on the maximum partial
likelihood estimates) was used. The elimination of outliers was performed through a
graphical examination of Cook's Distance (any value that was ≥ 4/n) and through the
elimination of any standardized residual ≥ 3.0 SD units.
In order to determine whether those that were classified as being "at-risk" for
MetS were any different compared to those who were not "at-risk" for being classified for
MetS, associations between MetS risk (yes, no) and five other categorical variables (level
of education, employment status, race/ethnicity, current smoker, food insecurity) were
examined.
Mann-Whitney U tests were used to compare questionnaire scores between
groups. Pain chronicity (number of years), pain severity (0 to 20), number of pain
descriptors (0 to 15), the total number of medications taken (0 to 21), perceived stressed
score (0 to 16), PHQ-4 anxiety score (0 to 6), PHQ-4 depression score (0 to 6), ISS score
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(0 to 28), and the GSES-6 score (6 to 24) between those who were classified as being "atrisk" for MetS compared to those who were not classified as being "at-risk" for MetS.
Several tests of covariance analyses (ANCOVA) were performed to determine
whether one or more physical performance characteristics were different between those
classified as being "at-risk" for MetS compared to those that were not. The covariates,
sex, and age were controlled for, and physical performance measures for
aerobic/functional capacity continuous value (predicted VO2max, distance walked over
two-minutes, peak expiratory flow rate (L/min), number of sit-to-stand reps in 30seconds) and upper body strength (combined right and left hand grip strength scores)
were compared between groups.
Statistical analyses were conducted using SPSS version 27 (IBM® SPSS®
Statistics, Chicago, IL) by G.S. Zavorsky, Ph.D. University of California, Davis. An α of
0.05 was set to signify statistical significance.
Latent class analyses were performed using MPlus (Muthen & Muthen, 2005).
Variables used in the model included pain severity, reported number of pain regions,
selection of affective pain descriptors, number of pain descriptors chosen, pain constancy,
pain self-efficacy, general self-efficacy, stress, anxiety, depression, sleep disturbance,
metabolic syndrome risk, peak expiratory flow rate, aerobic capacity (VO2max), right
grip strength, left grip strength, 30-second sit-to-stand test, and gait speed. Each variable
was grouped dichotomously to allow for a “positive”/ “negative” outcome. For the
purpose of this analysis, a “positive” outcome was the presence of the less favorable
outcome (higher pain severity, more regions of pain, presence of affective pain
descriptors, more pain descriptors chosen, presence of constant pain, lower pain self-
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efficacy, lower general self-efficacy, higher stress, presence of potential anxiety, presence
of potential depression, presence of potential sleep disturbance, presence of metabolic
syndrome risk, lower peak expiratory flow rate, lower aerobic capacity, lower grip
strength, fewer repetitions on the 30-second sit-to-stand test, slower gait speed). For the
variables of anxiety (PHQ-4), depression (PHQ-4), sleep disturbance (ISS), MetS risk,
30-second sit-to-stand, and gait speed, the published cut-off scores described previously
in the methods for these measures were used to dichotomously group the sample. For the
variables of pain severity, reported number of pain regions, number of pain descriptors
chosen, pain self-efficacy (PSEQ-2), general self-efficacy (GSES-6), and stress (PSS-4),
the median score of the sample was used as a cut-off to dichotomously group the sample.
If affective pain descriptors were chosen or if the subject marked “yes” to having
constant pain, then they were considered “positive” for the presence of those items. For
the physical measures of peak expiratory flow rate, aerobic capacity, and grip strength,
scoring lower than the published normative range previously described in the methods
grouped a subject as “positive” for the presence of these items.
Latent class modeling was performed starting with a one-class model and
increasing by one class each time modeling was performed. Model fit was assessed using
Akaike information criterion (AIC), Bayesian information criterion (BIC), and samplesize adjusted BIC, model entropy, the Vuong-Lo-Mendell-Rubin Likelihood Ratio Test
(LRT), the Lo-Mendell-Rubin Adjusted LRT, and the parametric bootstrapped LRT.
Lower values of AIC, BIC, and sample-sized adjusted BIC, along with higher model
entropy, signify better model fit

214,218

Likelihood ratio tests are used to determine

significance (P < 0.05) of the model compared to a model with an additional class added
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219,220,221

Therefore, the model with the lowest AIC, BIC, and sample-sized adjusted BIC,

and with the highest model entropy, that remained significant across the LRTs was
selected as the model of best fit. A minimum sample size of 200-subjects has been
recommended to perform a latent class analysis
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214,222,223

CHAPTER 4. RESULTS
4.1

Descriptive Statistics
The mean patient presentation was an age of 46.87 years (SD: 12.10), pain

chronicity of 3.82 years (SD: 6.68), usual pain intensity of 11.24 (SD: 5.42) on a scale of
0 to 20, selection of 4.45 (SD: 3.01) pain descriptors out of a total of 14, PSEQ-2 score of
5.65 (SD: 3.60) on a scale of 0 to 12, GSES-6 score of 16.73 (SD: 3.69) on a scale of 6 to
24, PSS-4 score of 7.12 (SD: 3.14) on a scale of 0 to 16, ISS score of 11.27 (SD: 7.58) on
a scale of 0 to 28, taking 3.55 (SD: 3.43) medications.
4.1.1

Descriptive statistics: Socioeconomic Variables

Of patients attending the PTPBC, 76.59% were aged between 31 and 60 years of
age and 61.81% of patients identified as female. Regarding employment and education,
79.26% of patients reported being employed full- or part-time and 83.53% reported not
earning a college or technical school degree. The most common race/ethnicities reported
were Black/African-American (34.0%), White/non-Hispanic (31.33%), Latino/Latinx
(14.22%), and Asian (4.44%). Food insecurity was present in 24.76% of the sample and
27.5% reported currently smoking.

Table 4.1: Socioeconomic Variables
Age (n = 504; mean: 46.87; SD: 12.10)
18 to 20
21 to 30
31 to 40
41 to 50
51 to 60
61 to 70
71 to 80
81 to 90
Sex (n =495)
Female
Male
Employment status (n = 459)
Full-time employed
Part-time employed
Unemployed
Disabled
Highest level of education (n = 443)
Did not complete high school
High school/GED completed
Some college or technical school
College or technical school completed
Some postgraduate school
Master’s degree
Advanced academic or clinical degree
Race/ethnicity (n = 450)
Black/African-American
White/non-Hispanic
Latino/Latinx
Asian
Black/African
Native American/Indigenous
Black/Latin American/Caribbean
Middle Eastern
Pacific Island
Multiracial/Other
Refused to answer
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Number of patients

Percentage

10
49
87
139
160
49
8
2

1.98
9.72
17.26
27.58
31.75
9.72
1.59
0.40

306
189

61.81
38.18

143
219
48
49

31.55
47.71
10.46
10.68

90
130
150
48
12
9
4

20.32
29.35
33.86
10.84
2.71
2.03
0.90

153
141
64
20
11
5
2
2
0
41
11

34.0
31.33
14.22
4.44
2.44
1.11
0.44
0.44
0.0
9.11
2.44

Table 4.1 (continued): Socioeconomic Variables
Number of patients

Food insecurity (n = 420)
Yes
No
Current smoker (n = 440)
Yes
No
4.1.2

Percentage

104
316

24.76
70.22

121
319

27.5
72.5

Descriptive Statistics: Pain Characteristics

Pain was reported in one or two body regions by 70.99% of patients and three or
more body regions by 18.05%. Forty-two (8.52%) patients met the criteria for having
widespread pain. Pain in the upper extremity was reported by 154 patients, pain in the
lower extremity by 240 patients, and pain in the axial skeleton (cranial and spinal
regions) by 257 patients. The majority of patients met the temporal definition of chronic
pain, with 98.78% of patients reporting a pain duration of one-year or greater. Usual pain
intensity greater than 10 on a 20-point scale was reported by 62.78% of patients. Over
half of patients (51.88%) described their pain as constant. Selection of pain descriptors
reflecting an emotional/affective component of the pain experience was present in
39.20% of patients and 23.66% of patients selected a total of seven or more pain
descriptors.
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Table 4.2: Pain Characteristics
Pain location (n = 493)
Pain not chief complaint
Axial
One LE
One UE
Both LE
Both UE
Axial + One LE
Axial + One UE
One LE + One UE
Axial + Both LE
Axial + Both UE
One LE + Both UE
One UE + Both LE
Axial + One LE + One UE
Both LE + Both UE
Axial + One LE + Both UE
Axial + One UE + Both LE
Axial + Both LE + Both UE
Regions involved (n = 493)
Zero
One
Two
Three
Four
Five
Region location (n = 493)
Axial
UE
LE
Regional versus Widespread (n = 493)
Regional
Widespread
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Number of patients

Percentage

54
103
83
54
28
4
49
25
4
22
13
1
1
10
7
10
2
23

10.95
20.89
16.84
10.95
5.68
0.81
9.94
5.07
10.95
4.46
2.64
0.20
0.20
2.03
1.42
2.03
0.41
4.67

54
240
110
47
19
23

10.95
48.68
22.31
9.53
3.85
4.67

257
154
240

52.13
31.24
48.68

451
42

91.48
8.52

Table 4.2 (continued): Pain Characteristics
Number of patients

Percentage

6
241
52
38
19
17
4
9
14
4
58

1.22
48.88
10.55
7.71
3.85
3.45
0.81
1.83
2.84
0.81
11.76

50
98
108
106
84

11.21
21.97
24.21
23.77
18.83

176
273

39.20
60.80

197
145
80
20
6

43.97
32.37
17.86
4.46
1.34

234
217

51.88
48.11

Chronicity (n = 462; mean: 3.82; SD: 6.68)
< 1 year
1 to 1.99
2 to 2.99
3 to 3.99
4 to 4.99
5 to 5.99
6 to 6.99
7 to 7.99
8 to 8.99
9 to 9.99
> 10 years
Usual pain intensity (n = 446; mean: 11.24; SD: 5.42)
0 to 4
5 to 8
9 to 12
13 to 16
17 to 20
Emotional/affective descriptor (n = 449)
Yes
No
Number of descriptors (n = 448; mean: 4.45; SD: 3.01)
0 to 3
4 to 6
7 to 9
10 to 12
13 to 15
Constant pain (n = 451)
Yes
No

Using the pain descriptors chosen, a correlation matrix was performed to
determine what percentage of subjects selecting one pain descriptor also chose other pain
descriptors. The following table lists the pain descriptors that could be selected in the
left-most column, the number of subjects selecting that pain descriptor in the next
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column, and then the percentage of those subjects that also selected the pain descriptors
listed in the following columns. The table is color-coded for ease of interpretation, with
percentages 25-49.99% highlighted as green, 50-74.99% highlighted as yellow, and 75100% highlighted as orange. The five pain descriptors (throbbing, tiring/exhausting,
sharp, stabbing, aching) included in this table were those that were selected by at least
75% of the subjects selecting a pain descriptor in the left-most column.

Table 4.3: Pain Descriptors Correlation Matrix
Percentage

Count
220

Throbbing
-

Tiring/
Exhausting
0.41

Hot/Burning

129

0.64

0.43

0.71

0.62

0.74

Sickening

33

0.82

0.76

0.76

0.73

0.88

Cramping

104

0.67

0.55

0.75

0.6

0.74

Gnawing
Tiring/
Exhausting

48

0.58

0.6

0.67

0.56

0.85

140

0.64

-

0.69

0.56

0.78

Sharp

256

0.6

0.38

-

0.58

0.7

Tender

152

0.59

0.49

0.7

0.51

0.78

Splitting

36

0.75

0.53

0.72

0.78

0.78

Stabbing

181

0.62

0.44

0.82

-

0.73

Heavy
Punishing/
Cruel

111

0.63

0.64

0.71

0.58

0.67

63

0.65

0.62

0.86

0.67

0.76

Shooting

179

0.67

0.42

0.78

0.59

0.77

Aching

286

0.59

0.38

0.63

0.46

-

Fearful

38

0.71

0.76

0.82

0.76

0.79

Throbbing
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Sharp
0.7

Stabbing
0.51

Aching
0.76

As displayed above, those selecting the affective descriptors of sickening and
fearful often chose multiple other pain descriptors. Aching and sharp were most
commonly chosen with other pain descriptors.
4.1.3

Descriptive statistics: Emotional Health and Sleep

Patients scoring less than 6 on a 12-point scale for the PSEQ-2 was 62.01% of the
sample. Around 28% of the sample reported a score of 15 or less on the GSES-6 which
has a possible range of 6 to 24. Scores on the PSS-4 ranged between 5- and 12-points out
of a total of 16-points in 76.36% of the sample. Potential anxiety was present in 33.01%
of patients, potential depression in 28.64%, and potential PTSD in 19.91%. Using the cutoff score of 10-points on the ISS,183 54.63% of patients presented with potential sleep
disturbance. Moderate to high risk of OSA was present in 53.76% of patients.

Table 4.4: Emotional Health and Sleep

Number of patients
Pain Self-Efficacy Scale 2-item (n = 408; mean: 5.65; SD: 3.60)
(Low)
0 to 2
96
3 to 4
69
5 to 6
88
7 to 8
57
9 to 10
51
(High)
11 to 12
47
General Self-Efficacy Scale 6-item (n = 390; mean: 16.73; SD: 3.69)
(Low)
6 to 9
21
10 to 12
35
13 to 15
54
16 to 18
175
19 to 21
72
(High)
22 to 24
33
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Percentage
23.53
16.91
21.57
13.97
12.50
11.52
5.38
8.97
13.85
44.87
18.46
8.46

Table 4.4 (continued): Emotional Health and Sleep
Number of patients
Perceived Stress Scale (n = 406; mean: 7.12; SD: 3.14)
(Low)
0 to 4
82
5 to 8
201
9 to 12
109
(High)
12 to 16
15
Patient Health Questionnaire – 4: Anxiety (n = 418)
Yes
138
No
280
Patient Health Questionnaire – 4: Depression (n = 412)
Yes
118
No
304
The Primary Care PTSD Screen for DSM-5 (n = 422)
Yes
84
No
338
Insomnia Severity Scale (n = 410; mean: 11.27; SD: 7.58)
(Low)
0 to 4
100
5 to 8
73
9 to 12
71
13 to 16
53
17 to 20
53
21 to 24
39
(High)
25 to 28
21
STOP BANG OSA risk (n = 452)
Low risk
209
Intermediate risk
161
High risk
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4.1.4

Percentage
20.20
49.51
26.85
3.69
33.01
62.22
28.64
73.79
19.91
80.10
24.39
17.80
17.31
12.93
12.93
9.51
5.12
46.24
35.62
18.14

Descriptive statistics: Physical health

In regards to blood pressure, 82.96% of patients had readings greater than 120/80
mmHg, with 43.47% of patients with hypertension meeting the criteria for stage II
hypertension. Using WtHR, 85.25% of patients had elevated body mass measures, with
the majority (58.59%) falling in the morbidly obese range. Similarly, using body mass
index, 84.53% of the sample had elevated body mass, with 54.57% falling into obese
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categories. Just over half of patients (50.11%) were at risk for metabolic syndrome. Peak
expiratory flow rate values were below normal levels in 64.72% of the sample. Predicted
VO2max values were scored “fair”, “poor”, or “very poor” in 53.28%. Grip strength was
measured to be low in 48.16% and 42.42% for the right and left side, respectively. The
majority of patients (75.80%) scored below the cut-off values on the 30-second sit-tostand test and in the total fall risk screening 85.27% were classified as at risk for falls.
Gait speed was also found to be low in the majority of the sample (92.06%) as measured
by the two-minute walk test. Using a definition of polypharmacy as regular use of five or
more medications,224 27.89% patients were categorized as under polypharmacy
management. Just under half of patients reported some kind of regular exercise with 0 to
1 exercise sessions per week being the most common response (58.19%). Using the
physical activity guidelines for an exercise frequency of most days per week,225 20.35%
of patients met the frequency criteria. When exercising, the majority of patients (82.06%)
reported a light intensity level (“take it easy”). Exercise session duration was reported
most often to be less than 30 minutes (77.23%).

Table 4.5: Physical Health Measures

Number of patients
Number of medications (n = 459; mean: 3.55; SD: 3.43)
0 to 2
212
3 to 4
119
5 to 6
50
7 to 8
36
9 to 10
18
>10
24
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Percentage
46.19
25.93
10.89
7.84
3.92
5.23

Table 4.5 (continued): Physical Health Measures
Number of patients

Blood pressure (n = 452)
Normal
Prehypertensive
Stage I
Stage II
Hypertensive crisis
Body mass index (n = 460)
Underweight (< 18.5)
Normal (18.5 – 24.9)
Overweight (25 – 29.9)
Obese (30.0 – 39.9)
Extreme Obesity (≥ 40)
Waist-to-height ratio (n = 454)
Extremely slim
Slim
Healthy
Overweight
Very overweight
Morbidly obese
Metabolic syndrome risk (n = 437)
Yes
No
Peak expiratory flow rate (n = 445)
Very low
Low
Normal
Predicted VO2max (n = 458)
Very poor
Poor
Fair
Good
Excellent
Superior
Right grip strength (n = 461)
Low
Normal
High
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Percentage

77
111
96
163
5

17.04
24.56
21.24
36.06
1.11

7
78
124
184
67

1.52
16.96
26.96
40.0
14.57

2
16
49
57
64
266

0.44
3.52
10.79
12.56
14.10
58.59

219
218

50.11
49.89

74
214
157

16.63
48.09
35.28

54
74
116
128
60
26

11.79
16.16
25.33
27.95
13.10
5.68

222
217
22

48.16
47.07
4.77

Table 4.5 (continued): Physical Health Measures
Left grip strength (n = 462)
Low
Normal
High
30-second sit-to-stand (n = 438)
Low
Normal
Fall risk (n = 448)
Yes
No
Two-minute walk test (n = 428)
Low
Normal
High
“Do you exercise?” (n = 443)
Yes
No
“How frequently do you exercise?” (n = 452)
0 to 1 time per week
2 to 3 times per week
4 to 6 times per week
Daily
“How hard do you push yourself?” (n = 457)
Take it easy
Heavy breath and sweating
Push near exhaustion
“How long does each session last?” (n = 448)
Less than 30 minutes
Greater than 30 minutes
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Number of patients

Percentage

196
217
48

42.42
46.97
10.38

332
106

75.80
24.2

382
66

85.27
14.73

394
33
1

92.06
7.71
0.02

215
228

48.53
51.47

263
97
44
48

58.19
21.46
9.73
10.62

375
9
73

82.06
1.97
15.97

346
102

77.23
22.77

4.2

Regression Analysis
4.2.1

Predictors of MetS Risk

Binary logistic regression was conducted to determine which independent
variables were predictors of MetS risk. Data screening eliminated nine outliers (2% of the
data). Regression results indicated that the overall model fit of two predictors (systolic
blood pressure and waist circumference) was statistically reliable in distinguishing
predicted MetS risk [-2 Log-Likelihood = 211, ꭓ2 (2) = 360, p < 0.001]. The model
correctly classified 87% of the cases. Approximately 58% to 78% of the variance in
predicting MetS risk was accounted for by systolic blood pressure and waist
circumference. For each one mmHg increase in systolic blood pressure, the likelihood of
being classified as being “at-risk” for metabolic syndrome increases by about 16 to 27%
(OR=1.21; 95% CI: 1.16-1.27). That is to say, if a subject’s systolic blood pressure were
to increase one mmHg from their original measurement, then the likelihood of being
classified as “at-risk” for MetS would increase, at the lower end, 16%. Similarly, for
every one cm increase in waist circumference from a subject’s original value, the
likelihood of being classified as being “at-risk” for metabolic syndrome increases by
about 14 to 24% (OR=1.19; 95% CI: 1.14-1.24). Thus, an increase in systolic blood
pressure by 5 mmHg and an increase in waist circumference of 5 mmHg would increase
the relative risk of being classified as “at risk” of MetS approximately 2-fold. However,
absolute risk would be lower for a subject, for example, increasing in systolic blood
pressure from 110 mmHg to 120 mmHg and waist circumference from 70 cm to 75 cm
compared to a subject increasing in these measures from 145 mmHg to 150 mmHg and
120 cm to 125 cm.
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4.2.2

Associations Between MetS Risk and Social Determinants of Health

In order to determine whether those that were classified as being “at-risk" for
MetS were any different in social determinants of health compared to those who were not
"at-risk" for being classified for MetS, associations between MetS classification risk (yes,
no) and five other categorical variables were examined. Only race/ethnicity (Phi
Coefficient = 0.20 to 0.39, p = 0.018, n = 296) and not smoking (Phi Coefficient = -0.24
to -0.01, p = 0.04, n = 296) were statistically associated with being classified as “at-risk”
for MetS; however, these associations were weak. Nonetheless, the data demonstrate that
if racial/ethnic differences were examined between patients identifying as White/nonHispanic and patients identifying as Black/African Americans, patients identifying as
Black/African Americans were 1.2 to 3.6 times more likely to be classified as "at-risk"
for MetS compared to those identifying as White/non-Hispanic (p = 0.009, n = 224).
Furthermore, smoking tends to elicit a protective effect against MetS as smoking tended
to reduce the likelihood of being classified as being "at-risk" for MetS by 10 to 70% (p =
0.02, n = 224). Yet, again, it must be stressed that caution is warranted since the
percentage of shared variance between the classification of MetS risk versus
race/ethnicity and smoking was small (less than 7% shared variance).
4.2.3

Differences Between Groups in Pain, Medications, Perceived Stress, Anxiety,
Depression, Insomnia, and General Self-Efficacy
Mann-Whitney U tests determined that only the number of medications taken

were significant between the two groups (p < 0.01). Those who were classified as "atrisk" for MetS took more than one more medication (median number of medications = 3)
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compared to the group that was not classified as being at risk for metabolic syndrome
(median number of medications = 2). No other non-parametric variable (pain chronicity,
pain severity, number of pain descriptors chosen, perceived stress, anxiety, depression,
insomnia, general self-efficacy) was different between those “at-risk” for MetS versus
those not at risk for MetS.
4.2.3

Differences Between Groups in Physical Performance

There were physical performance differences between those who were classified
as “at risk" for MetS compared to those who were not, even after controlling for sex and
age. An analysis of covariance in over 350 subjects determined that estimated peak
oxygen uptake (VO2max) was 6 mL/kg/min (~20%) lower, two-minute walk test distance
was 11 m (~9%) less, number of sit-to-stand reps in 30-seconds was 1.3 reps fewer
(~14%), and summed right and left hand grip strength was 5 kg (~8%) higher in those
that were classified as "at-risk" for MetS compared to those that were not classified as at
risk, when controlling for age and sex, (all p < 0.05). Peak expiratory flow rate was not
different between groups when controlling for sex and age. Sex and age significantly
influenced most of these physical performance variables.

4.3

Latent Class Analysis
Latent class analysis uses cross-sectional latent variable mixture modeling to

assess the individual profiles of the included subjects in regards to the measures included
in the model.218,226 Individuals are then assigned to a class based on the probability that
their measures are most similar to other members of the class.226 This ultimately creates
subgroups where members are most similar to those in their class while at the same time
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most distinct from the individuals belonging to the other classes.226,227 Model fit statistics
for latent class models (1 to 5) demonstrated that a 3-class model was most appropriate.
The 3-class model had the highest entropy and lowest AIC, BIC, and sample-size
adjusted BIC while maintaining statistical significance across the Vuong-Lo-MendellRubin LRT, the Lo-Mendell-Rubin Adjusted LRT, and the parametric bootstrapped LRT.
Table 4.6: Model Fit Statistics
# of
Latent
AIC
BIC
Classes

Adjusted
BIC

Entropy

LMR
LRT

LMR
Adjusted
LRT

Bootstrap
LRT

1

10123.5

10199.5

10142.3

2

9583.5

9739.7

9622.3

0.7

577.7*

573.1*

577.7

3

9446.6

9683.1

9505.3

0.7

174.9*

173.4*

174.9*

4

9365.7

9682.3

9444.3

0.7

119.0

118.0

119.0*

5

9299.1

9696.0

9397.7

0.7

105.4

104.5

105.4

* p < 0.05
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The following figure displays the grouping of the latent class analysis with each
variable included in the model listed on the X-axis and the percentage likelihood of a
member within each class that a subject would be classified as “positive” for each
variable.

3-Latent Class Analysis
100.0
90.0
80.0
70.0
60.0
50.0
40.0
30.0
20.0
10.0
0.0

Class 1,
29.8%

Class 2,
28.5%

Class 3,
41.7%

Figure 4.1: 3-Latent Class Analysis
Class-one represented 29.8% of the sample, Class-two 28.5% of the sample, and
Class-three 41.7% of the sample. Looking at the defining characteristics for each class,
members of Class-one were more likely to have higher pain severity, use more pain
descriptors, report constant pain, have low pain self-efficacy, low general self-efficacy,
high stress, anxiety, depression, and sleep disturbance. Thus, Class-one can be defined by
having a greater pain experience and greater psychosocial involvement than the other two
classes. Both Class-two and Class-three were less likely to report a greater pain
experience and were less likely to display high psychosocial involvement compared to
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Class-one. Separating Class-two and Class-three were mainly the measures of peak
expiratory flow rate and both right and left grip strength. Therefore, if Class-one is
characterized by higher pain/psychosocial involvement, Class-two is characterized by
lower pain/psychosocial involvement with poorer physical health measures, and Classthree is characterized by lower pain/psychosocial involvement with better physical health
measures.
The following table again lists the included variables along the left-most column
and the percentage likelihood a member of each class would classify as “positive” for
each variable. The table is color-coded for ease of interpretation, with percentages 024.99% highlighted as blue, 25-49.99% highlighted as green, 50-74.99% highlighted as
yellow, and 75- 100% highlighted as orange.
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Table 4.7: 3-Latent Class Analysis
Class
1,
29.8%

Class
2,
28.5%

Class
3,
41.7%

70.2

43.1

34.3

31.3

17.3

11.1

56.1

32.9

30.9

67.3

28.7

29.3

72.4

44.4

41.9

PSEQ

83.0

63.5

45.5

GSES

80.5

58.6

31.2

PSS

65.6

19.9

10.2

PHQ-4 A

79.6

11.3

11.5

PHQ-4 D

77.2

5.2

4.7

ISS

91.9

43.5

33.6

MetS

55.6

45.7

49.0

PEF

69.6

84.4

48.7

VO2

34.6

27.0

23.8

R grip

51.9

90.6

18.0

L grip
Sit-tostand
Gait speed

48.6

89.1

7.9

90.4

82.0

60.0

42.6

32.7

12.2

Pain
severity
# of
complaints
Affective
descriptors
# of
descriptors
Constant
pain

Again, Class-one demonstrates a greater likelihood of group members to have
high pain severity, use affective pain descriptors, use more pain descriptors, and have
constant pain, and are much more likely to have poorer scores as they relate to pain selfefficacy, general self-efficacy, anxiety, depression, and sleep disturbance. Class-two
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particularly stands out in measures of low peak expiratory flow rate and right and left
grip strength. Class-three does not stand out across all pain, psychosocial, and physical
health domains compared to the other two classes.
For ease of interpretation, the latent class analyses were also re-run removing
three variables from the model that did not show much differentiation between classes.
These variables were number of pain regions reported (# of complaints), risk of metabolic
syndrome (MetS), and aerobic capacity (VO2). Removing these variables did change the
model fit statistics and percentage of the sample belonging to each class, however, the 3class model again was identified as having the best fit using the previously described
criteria. The following figure shows the model with these variables removed to better
demonstrate the differentiation between classes.
3-Latent Class Analysis - Non-Discriminating Variables Removed
100.0
90.0
80.0
70.0
60.0
50.0
40.0
30.0
20.0
10.0
0.0

Class 1,
30.2%

Class 2,
27.7%

Class 3,
42.1%

Figure 4.2: 3-Latent Class Analysis with Non-Discriminating Variables Removed
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CHAPTER 5. DISCUSSION OF RESULTS
5.1

Descriptive Findings
5.1.1

Demographics and Social Determinants of Health

Differences between the clinical population of the PTPBC and the surrounding
community were identified along the social determinants of health. The population of
Guilford County, North Carolina, is estimated to be 50.5-55.8% White, 33.8-34.8%
Black/African American, and 7.8-9.1% Latino/Latinx.21,228 The clinical population at the
PTPBC was found to be more diverse, with 68.67% of patients reporting racial/ethnic
backgrounds other than White. The rate of college graduation was lower than that of
Guilford County (34.9%)228 with only 16.48% of patients attending the PTPBC reporting
having finished a college or technical degree. Guilford County unemployment is
estimated at 4.8% 228 of the population which is 5.88% less than the percentage of patients
reporting unemployment at the PTPBC (10.48%). Rates of food insecurity were higher in
the clinical population (24.76%) compared to rates in Guilford County (17.8-19%).21, 228
Current smoking status was also more common in the clinical population, with 27.5%
reporting currently smoking compared to 19.0% in Guilford County.228 Given the
diversity of the clinical population of PTPBC, it will be important to consider differences
in cultural beliefs as it relates to physical and emotional health as this can impact the
provider/patient relationship as well as health outcomes.229-231 It will also be beneficial to
identify community partners to help guide patients who are unemployed or under-skilled
in finding gainful employment or training opportunities to improve financial stability and
quality of life. However, employment is also a larger societal issue as respondents to the

Guilford County Community Health Assessment identified a lack employment
opportunities offering benefits and livable wages as well as a paucity of train-to-work or
training-for-advancement opportunities by community employers to be barriers to career
development.21 While patients with food insecurity are able to use the PTPBC food
pantry during their time at their clinic, part of discharge planning for this patient
population will require that these patients be aware of other food pantry locations in the
community for more sustainable access to food. Last, identification of local no-cost or
low-cost smoking cessation programs within the community, particularly those taking
into account the barriers of smoking cessation in lower socioeconomic groups,232 is a
priority to lower smoking rates of the PTPBC clinical population. In summary, improving
access to health and wellness opportunities through pro bono services and referral to
community partners can help reduce health inequities, however, advocacy at local, state,
and national levels needs to occur to ensure that those resources exist for marginalized
populations.
5.1.2

Measures of Emotional Health and Sleep

The prevalence of depression in the Piedmont region of North Carolina was
estimated at 20.9% in 2019 using a survey asking respondents if they have been given the
diagnosis of depression by a healthcare provider.233 A recent survey of North Carolina by
the National Center for Health Statistics asking about active symptoms of depression or
anxiety estimated that the prevalence of depressive symptoms at 24.1% of the population
and symptoms of anxiety at 32.1%.234 Using the PHQ-4, potential depression was present
in 28.64% of the clinical population at the PTPBC while potential anxiety was present in
33.01%. Therefore, prevalence of these mental health conditions was fairly similar
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between these two populations using these measures. Still, given the association of
emotional distress to pain,115,116,120 along with the barriers to mental health support in
Guilford County,21 identifying or establishing access to mental health care for those
without resources is an important consideration for the PTPBC in improving quality of
life for the patient population. Similarly, the lifetime prevalence of PTSD in the Piedmont
region of North Carolina was estimated to be 1.30% of the population in the early
1990s,235 while estimates nationally for lifetime prevalence are reported at 6.8%.236 With
nearly 20% of patients potentially having PTSD using the PC-PTSD-5 screening
questionnaire, the prevalence of PTSD within the clinical population at the PTPBC may
be much higher than the rest of the state. This is an interesting consideration for future
lines of research given the potential discrepancy in PTSD prevalence between this
population and the general population. Regarding perceived stress, the PSS-4 has been
studied across a general sample of 1568 English subjects and a mean score of 6.11 (SD:
3.14) was identified.237 The clinical sample at the PTPBC demonstrated a similar mean of
7.12 (SD: 3.14), demonstrating that the sample as a whole did not demonstrate higher
levels of stress compared to a more general population.
Sleep disturbance has also been associated with the development and
maintenance of pain.118-120 In North Carolina, it is estimated that 32.5% of the population
experience short sleep (< 7 hours).238 In the PTPBC clinical population, 54.63% were
identified as having potential sleep disturbance using a cut-off score of 10 or greater on
the ISS.183 Therefore, specific interventions to improve sleep quality and quantity is an
important consideration in improving the health and wellbeing of the patients attending
the clinic. Similarly, moderate to high risk of OSA was present in 53.76% of patients
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attending the PTPBC. A 2007 study through the North Carolina Family Practice Research
Network identified that 13-33% of 1935 patients reported symptoms of sleep apnea.239
The potentially higher rates of OSA in the PTPBC, which is related to the higher rates of
obesity, is of note not only due to the higher risk of development of other chronic
diseases associated with OSA,240,241 but also due to the potential barriers of being
evaluated by a sleep specialist and the high cost of the equipment used to manage OSA
for a patient population with lower socioeconomic status and lack of health insurance.
The GSES and the PSEQ have been studied in patients with chronic conditions
and pain conditions. The full version of the GSES is 10-items with total scores ranging
from 10- to 40-points,197 with higher scores implying higher general self-efficacy. Mean
scores for the GSES for patients with arthritis have been reported to range from
28.71(SD: 5.1) to 30.23 (SD: 4.8).242 Other populations have been studied including those
without impairment (28.77; SD: 5.37), college students (30.35; SD: 4.00), professional
swimmers (30.45l SD: 4.98), patients with coronary heart disease (32.11; SD: 0.52), and
patients with gastrointestinal diseases (28.61; SD 5.33).243 Thus, mean scores on a 40point scale ranged from approximately 28- to 32-points. Considering a score of 30-points,
this would represent a patient selecting 20-points of the 30-points possible on the 10- to
40-point scale, or 66.67%. Using the short-form GSES, the 6-item tool scored from 6- to
24-points, revealed a mean score of 16.73 (SD: 3.69) for the patients attending the
PTPBC. Rounding to 17-points, this would represent a patient selecting 11-points of the
18-points possible on the 6- to 24-point scale, or 61.11%, which is only slightly lower
than the other populations. Similarly, the full version of the PSEQ has also been studied
in populations with pain.244,245 The full version of the PSEQ is a 10-item questionnaire
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with a total score ranging from 0- to 60-points,244 with higher scores implying higher pain
self-efficacy. In two studies in populations with pain, Nicholas et al identified a mean
score of 25.8 (SD: 12.4) and 20.7 (SD: 13.3).244,245 Thus, of the available points, the mean
subject selected approximately 43.33% and 35.0% of the available 60-points. Using the
two-item PSEQ, the mean score of the patient population at the PTPBC was found to be
5.65 (SD: 3.60), or 47% of the available 12-points, demonstrating potentially higher pain
self-efficacy compared to the Nicholas et al trials.
5.1.3

Physical Measures of Health

In the clinical population, obesity was present in 54.57% using BMI and 58.59%
using WtHR, both of which are higher than the county estimates (30.6%) for obesity.21
Regional estimates of the percentage of adults participating in at least 150 minutes of
physical activity per week is 52.5% of the population.21 Only 20.35% of the clinical
population attending the PTPBC reported exercising 4-7 days per week. In North
Carolina, it is estimated that 32.2-34.7% of the population has been diagnosed with
hypertension.246 The clinical population at the PTPBC demonstrated much higher rates
with 58.41% presenting with stage I hypertension or higher and 24.56% being
prehypertensive. A study performed of 217,056 individuals attending the Carolinas
HealthCare System’s facilities in North Carolina in 2014 found that 22.5% of this
population was diagnosed with MetS using the National Cholesterol Education Program
Adult Treatment Panel III criteria.247 While laboratory confirmed MetS was not captured
in the clinical population at the PTPBC, 50.11% were at risk of MetS based on the noninvasive model reported by Romero-Saldaña et al161 potentially demonstrating a higher
rate of MetS. Compared to published normative values, much of the clinical population
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also scored below normative values on the measures of physical health. In regards to
cardiovascular and pulmonary health, peak expiratory flow rate was measured below
normal in 64.72% 164,165,205 of the sample and aerobic capacity was estimate to be fair or
worse in 53.25%.169 Functional musculoskeletal measures included grip strength, the 30second sit-to-stand test, and the two-minute walk test. Right grip strength was below
normative values in 48.16% of the sample and left grip strength was low in 42.42%.206-208
Approximately 75% of the sample did not meet the expected repetitions on the 30-second
sit-to-stand test178 and nearly all subjects (92.06%) were measured to have lower than
expected scores on the two-minute walk test.209 Between measures of blood pressure,
body mass, cardiovascular and pulmonary function, and musculoskeletal functional
measures, there appears to be a large need for health and wellness opportunities for this
patient population. Remembering the perceived barriers to regular exercise for Guilford
counties include not having safe and affordable facilities along with not knowing how to
begin exercising,21 initiatives for the PTPBC to develop exercise and wellness options for
the community to engage with beyond the physical therapy plan of care can be an area to
make a significant impact on improving health disparities.
5.1.4

Comparison to Other Pro Bono Physical Therapy Clinics

Creps et al assessed the demographics and chronic health conditions of a sample
of 29 patients aged 18-years and older attending a student-run pro bono physical therapy
clinic in Michigan, United States.248 Ten subjects reported their sex to be female (34.5%)
and 48.2% of the sample were between the ages of 45- and 64-years.248 Measured blood
pressures found that 82.8% of the sample registered readings greater than 120/80 mmHg,
with 31.0% fulfilling the criteria for stage I hypertension and 6.9% meeting the criteria
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for stage II hypertension.248 Depression was self-reported by 20.7% and difficulty
sleeping by 75.9%.248 Measures of BMI found that 24.1% of the sample was overweight
and 37.9% had a BMI of 30-39.9 (obese).248 No patients were measured to have a BMI
greater than or equal to 40.248 Comparatively, the population sampled at the PTPBC had a
higher representation of the female sex (61.8%), higher prevalence of stage II
hypertension (36.1%), lower prevalence of depression as determined by the PHQ-4
(28.6%) and sleep difficulties as measured by the ISS (54.6%). Regarding BMI,
approximately 27.0% of the sample was overweight, 40.0% obese (BMI 30.0 -39.9), and
14.6% with a BMI greater than or equal to 40.
Stickler et al similarly assessed a sample of 28 patients aged 20-69 years
attending a student-run pro bono physical therapy clinic in Kansas, United States.249 Over
half (53.6%) of patients reported belonging to the female sex with 53.5% of patients
falling within the age range of 40- to 59-years.249 Unemployment was reported by 75% of
the sample,249 a much higher percentage than those at the PTPBC (10.5% unemployed;
10.7% disabled). Outcome measures collected included a numeric pain rating scale (010), a visual analog scale for quality of life (0-100), the Short Form-8 (SF-8)
questionnaire mental and physical health subscales, and systolic and diastolic blood
pressure.249 At baseline, mean pain severity of the sample was rated at 7.8 and mean
blood pressure was calculated to be approximately 135/85 mmHg,249 which were similar
to the higher pain severity reports and measured blood pressures at the PTPBC. After an
average of three visits, significant differences (p<0.05) were found in follow up pain
severity scores (7.8 to 3.7) and SF-8 physical health scores (32.71 to 36.88).249 No
significant differences were found in the visual analog scale for quality of life (58.13 to
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61.31), SF-8 mental health (38.29 to 42.24), or blood pressure (approximately 135/85
mmHg to 134/85 mmHg).249
In summary, along with complaints in pain and function, many patients attending
pro bono physical therapy clinics are also presenting with unmet needs in regards to
physical, mental, and socioeconomic health. Therefore, as pro bono care grows in
physical therapy settings, consideration must be placed on how to connect these patients
to opportunities to address these domains of health and wellness to improve not just pain
and function, but also quality and longevity of life.
5.1.5

Comparison to Other Pain Clinics

May et al assessed a clinical population of 935 patients attending a communitybased multidisciplinary chronic pain clinic in British Columbia, Canada.250 Regarding the
demographics and social determinants of health for this group, the mean age was 49.5
(SD: 14.9), 69.1% reported sex as female, 27.9% were non-white, 56.3% were not
employed full- or part-time, and 60.2% had not earned higher than a high school
degree.250 Mean age and sex were similar to the population at the PTPBC, however,
fewer patients in the PTPBC were not working (21.2%), a greater number of patients
were non-white (68.67%) and had not earned higher than a high school degree (83.5%).
Regarding pain characteristics, 93.5% of the sample attending the
multidisciplinary chronic pain clinic reported a pain duration of greater than one year,
with 51.1% describing pain in more than one area, and the most common primary areas
of pain to be the lower back (25.2%), buttock/pelvis/hip (20.8%), head and jaw (14.7%),
and neck (14.1%).250 Pain severity (0-10) was rated greater than 4 (moderate-to-severe) in
84.3% of patients.250 Patients at the PTPBC similarly had pain greater than 1-year in
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duration (98.8%). Fewer patients reported moderate-to-severe pain (66.9%) and fewer
had pain in more than one location (40.2%). Reports of axial pain were high (52.1%),
followed by lower extremity symptoms (46.7%), and upper extremity symptoms
(31.24%).
Assessing emotional health, 59.9% of patients at the multidisciplinary chronic
pain clinic were classified as having moderate or severe depression using the Patient
Health Questionnaire – 9.250,251 Using the full Pain Self-Efficacy Questionnaire,
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the

mean of the sample was found to be 29.2 (SD: 13.56) out of 60 points.250 Fewer patients
at the PTPBC were identified as having any type of potential depression using the PHQ-4
(28.6%), however, a similar mean score of 5.65 (SD: 3.60) out of 12-points was found on
the PSEQ 2-item questionnaire.
While there are similarities between the multidisciplinary chronic pain clinic and
the PTPBC, many differences were also highlighted between the two populations. It is
therefore important to perform descriptive research in each practice setting to best
identify the needs of the patient population not only clinically but also within the
surrounding community. Knowing the potential barriers to improving physical and
emotional health can lead to more targeted interventions clinically and initiatives socially
to address health inequities driving poorer health-related outcomes.

5.2

Findings from Regression Analysis
5.2.1

Predicting Metabolic Syndrome Risk

Through binary logistic regression, it was determined that systolic blood pressure
and waist circumference were the main factors that predict whether someone is classified
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as being "at-risk" for MetS risk or not. The model correctly predicted 87% of the cases,
demonstrating a good fit, but the odds ratios were small. Intuitively, blood pressure and
waist circumference should be main predictors of MetS risk because two of the five
components of metabolic syndrome include blood pressure (>130/85) and waist
circumference (≥ 89 cm for women, ≥ 102 cm for men).31 Blood pressure and waist
circumference were also likely found to be strong predictors as the criteria to determine
MetS risk161 in this study relied on measures of blood pressure and WtHR. Therefore,
when screening for MetS in a clinical setting without access to laboratory testing,
clinicians should continue to capture blood pressure, waist circumference, and height to
best inform their clinical decision making. The other measures included in the model
(sex, age, weight, BMI, hand grip strength, peak expiratory flow rate, predicted VO2max,
30-second sit-to-stand test, two-minute walk test, fall risk, PHQ-4 anxiety score, PHQ-4
depression score, PSS-4 score, ISS score, and GSES-6 score) were not helpful in
identifying those at risk for MetS. These measures can still be used to inform the clinician
about the physical and emotional health status of the patient, but they will not add any
additional insights regarding the patient’s risk of MetS.
5.2.2. Differences Between Groups in Socioeconomic, Pain, and Emotional Health
Measures
Race/ethnicity was marginally associated with MetS risk, meaning that patients
identifying as Black/African-American had a greater chance of being classified as "atrisk" compared to patients identifying as White/non-Hispanic. Patients who used more
medications were also more likely to be classified as being “at-risk” for MetS. In a
previous study, patients taking the most number of medications also had the highest
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systolic pressures and the largest BMI,252 which reflects the criteria for MetS diagnosis.
Conversely, smoking was found to be slightly protective against being classified as "atrisk" for developing MetS. This is congruent with other studies that have shown smoking
to be protective against developing MetS,253,254 in part due to the lower BMI and
narrower waists in smokers compared to non-smokers.255 Interestingly, there was no
association between MetS risk and pain chronicity, pain severity, number of pain
descriptors chosen, PSS-4 scores, PHQ-4 anxiety scores, PHQ-4 depression scores, ISS
scores, and GSES-6 scores. Thus, the hypothesis that MetS risk would be an important
variable to subgroup patients with pain complaints based on the shared physiological
pathways and risk factors was not supported by this study. While identification of MetS
risk remains an important clinical consideration for the physical health of the patient,
within this sample and the included methods, MetS did not inform the pain experience of
the patient.
5.2.2

Differences Between Groups in Physical Performance

While not diagnostic, physical performance measures were identified that differed
between those that were classified as being "at-risk" for MetS and those that were not at
risk. After adjusting for age and sex, those that were classified as "at-risk" for MetS had a
predicted VO2max of 27.8 compared to 29.2 mL/kg/min for those not at risk, a twominute walk distance of 106 m compared to 117 m, and completed only 8.1 compared to
9.6 reps in 30-seconds for the sit-to-stand test. These adjusted values were ~10 to 20%
lower compared to those that were not classified as being at risk for MetS. A recent
review has shown that there is a strong link between physical activity, aerobic fitness, and
the reduction in systolic blood pressure, improved lipid profiles, and reduction in
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metabolic syndrome prevalence.256 Therefore, it is expected that those “at-risk” for MetS
would demonstrate lower scores in measures of cardiovascular and pulmonary health and
musculoskeletal function.

5.3

Findings from the Latent Class Analyses
Latent class analysis identified three unique patient subgroups with distinguishing

characteristics. Class-one was more likely to present with a greater pain experience (high
pain severity, greater number and affective pain descriptors chosen, and pain constancy)
along with greater psychosocial involvement (lower pain self-efficacy, lower general
self-efficacy, higher stress, potential anxiety, potential depression, and potential sleep
disturbance). Class-two demonstrated a less impactful pain experience and lower
psychosocial involvement, but poorer scores on the physical health measures of peak
expiratory flow rate and right and left grip strength. Class-three, similar to Class-two,
demonstrated a less impactful pain experience and lower psychosocial involvement, but
instead demonstrated better scores on physical health measures. Therefore, when
hypothesizing strategies to maximize outcomes in each of the three classes, having a
greater focus on the psychosocial variables potentially influencing the pain experience
seems reasonable when managing a patient belonging to Class-one. Emphasizing
cardiopulmonary fitness and musculoskeletal strength along with other musculoskeletal
impairment would be a comprehensive approach to managing members of Class-two, and
primarily focusing on musculoskeletal impairments to manage members of Class-three
may be appropriate. Interestingly, MetS risk again was not a significant discriminating
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variable in the latent class analysis, which does not support the hypothesis that MetS
would be an important feature in subgrouping patients with pain complaints.
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CHAPTER 6. SUM M ARY, FUTURE DIRECTIONS, LIM ITATIONS, CONCLUSION
6.1

Summary and Clinical Directions
In summary, analysis of descriptive statistics revealed many components of

physical, emotional, and socioeconomic health that if addressed, could improve the
quality and longevity of life in the patient population at the PTPBC. Compared to the
general population, these indicators of poorer health were present as similar rates, or in
many cases, higher rates in the clinical population. As it relates to the patient’s pain
experience, psychosocial factors such as pain and general self-efficacy, stress, anxiety,
depression, and sleep disturbance appear to distinguish patients reporting greater pain
severity, number of and affective pain descriptors used, and pain constancy. The risk of
MetS was not an important distinguishing variable in regression analysis or latent class
analysis in identifying patient subgroups that may need to be managed differently to
promote better clinical outcomes. However, improving physical health measures remain
an important consideration as pro bono physical therapy grows as often these clinics will
serve as the main point of contact to healthcare for patients without health insurance. As
medical providers, physical therapists must consider the whole health of the patient for
intervention planning and triage, as well as creatively think about how to improve the
organizational structure of pro bono clinics to improve patient outcomes.
Managing multiple aspects of a patient’s health and wellness is an impossible task
for a single provider based on scope of practice, time, and resources.5,13 Thus, a
multidisciplinary team is ideal to promote the best outcomes for the patient population. A
review of organizational interventions to increase healthcare access and improve
outcomes for vulnerable populations investigated the most effective approaches to deliver

multidisciplinary care.257 The results of the 39 studies included in this review revealed
that “formal integration of services”, meaning patients are able to access multiple
providers at one time/location, resulted in a reduction in hospitalizations, fewer
emergency department admissions, and reduced the number of health care needs for the
populations studied. This model appeared to out-perform non-centralized services
requiring the coordination of a case worker or network of providers to facilitate referrals
between multiple locations. Therefore, as the PTPBC grows to meet the needs of the
clinical population, it will be important to integrate additional health and wellness
providers into the clinic so that patients can consult with the necessary professionals at
one point-of-service. Similarly, opportunities for physical therapists from the PTPBC to
consult with patients in the clinics of our community partners will also help move toward
a more integrated care model for the shared clinical population.
While access to quality medical and mental health care is paramount to manage
many comorbidities seen in the clinical population at the PTPBC, it is also important to
provide the clinical populations access to quality health and wellness opportunities to
improve quality of life. In particular, modification to diet, exercise habits, sleep patterns,
and breathing practices can have a significant impact on many of the physical and
emotional health measures explored in this study.
Many dietary approaches to improve health exist which can create confusion as to
which dietary guidelines are the best to follow. A recent meta-analysis reviewed 14
named diets: Atkins, Biggest Loser, DASH, Jenny Craig, Mediterranean, Ornish,
Paleolithic, Portfolio, Rosemary Conley, Slimming World, South Beach, Volumetrics,
Weight Watchers, and Zone.258 Across all diets, there was “moderate-certainty” evidence
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that at 6-months, modest reduction in body weight and substantial changes in SBP and
DBP could be achieved.258 There was little difference between diets regarding these
outcomes, therefore it appears personal preference for diet can be weighted more heavily
than the perceived efficacy when selecting one named diet program over another.258
However, with all the named diets, a regression to baseline body weight and blood
pressure was noted at 12-months.258 The authors cited that adherence to the diet programs
was usually not reported and therefore the trend back to baseline may be explained by
subjects not fully adhering to the dietary guidelines. The recently updated Dietary
Guidelines for Americans, 2020-2025, recommend nutrient-dense foods within calorie
limits that include vegetables of all types, fruits, grains (particularly whole grains), dairy
(particularly no- and low-fat), lean animal- and plant-based proteins, and healthy oils.259
Added sugars, saturated fat, sodium, and alcoholic beverages are limited in these
guidelines. Emphasis is also placed on customizing choices “to reflect personal
preferences, cultural traditions, and budgetary considerations.”259 Therefore, consulting
with a nutritional expert to navigate the options and personalize a dietary strategy can
promote early adherence to dietary habits. In order to maintain adherence to any
particular diet, it would be reasonable to have multiple patient interactions over a long
period of time to support motivation and address the individual needs of each patient.
Trained support staff or student volunteers could use telehealth or virtual platforms to
have scheduled check-ins with the patient, using strategies to support motivation or
identify when another visit with the appropriate provider is indicated.
Multiple options to engage in physical activity also exist, again making it difficult
for a patient to know where and how to start.21 The Department of Health and Human
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Services released the second-edition of the Physical Activity Guidelines for Americans in
2018.225 The goal of the physical activity guidelines is to recommend the proper dosage
of exercise that optimizes the physical and mental benefits of exercise including reduced
mortality, lowered risk of chronic disease, improved ability to perform daily tasks,
improved sleep, and reduced risk of depression, anxiety, and dementia.225 Using these
metrics, 150-minutes to 300-minutes of moderate-intensity aerobic, or, 75-minutes to
150-minutes of vigorous-intensity aerobic activity per week is recommended.225
Exercising beyond these time frames does provide further health benefits, however, the
dose-response relationship diminishes once exceeding 300-minutes of moderate- or 150minutes of vigorous-intensity aerobic activity.225 Along with aerobic activity, strength
training is also recommended to be performed two-days per week, targeting the major
muscle groups.225 According to Cochrane reviews, exercise as an intervention for pain
conditions such as fibromyalgia,260-262 non-specific low back pain,263-266 and neck pain267
may be a beneficial, however, more high-quality studies are necessary. Yet, emerging
evidence is indicating that the symptomatic improvements seen in these conditions with
exercise may not be due to improvement of physical health measures such as body
weight. In patients with knee osteoarthritis, “moderate-credibility” evidence
demonstrated that weight-loss interventions alone were not more effective than exercise
only for pain and disability.268 While improving physical health measures is still
important to improving quality and longevity of life, exercise is also of particular focus in
patients with musculoskeletal conditions due to other physiologic mechanisms that can
reduce pain symptoms. The term, “exercise-induced hypoalgesia”, has been coined to
capture the mechanisms of pain reduction with physical training.269-271 Mechanisms of
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aerobic and strengthening exercise-induced hypoalgesia include activation of central
endogenous opioid and serotonin pathways, as well as reducing inflammatory cytokines
and increasing anti-inflammatory cytokines.272-274 These mechanisms support a reduction
in pain symptoms along with any added benefit from improving cardiovascular or
musculoskeletal fitness through exercise. Much like diet, in order to sustain the benefits
of exercise, long-term adherence must be adopted by the patient. Given the benefits of
exercise for physical health, emotional health, and pain, strategies to improve long-term
exercise adherence has been of interest for researchers in both general populations and
those with musculoskeletal complaints.275-278 Briefly, evidence has shown that long-term
adherence to exercise can be supported by individualizing programs, supervising
sessions, offering booster sessions to review/revise programing, using motivational
strategies, and properly grading exercise to match the patient’s capabilities based on
physical health and pain symptoms. This is also supported by the physical activity
guidelines, which recommend people engage with any level of physical activity they are
capable of based on their individual needs regardless of whether or not it meets the
proposed guidelines.225 Meta-analysis has also demonstrated that longer duration, lowintensity cardiovascular training can improve aerobic capacity to the same extent as
shorter duration, high-intensity cardiovascular training,279 thus making aerobic exercise
to improve aerobic capacity more accessible to patients with pain interference. Again,
using support staff and student volunteers to regularly engage with patients regarding
physical activity and exercise adherence can promote more positive outcomes for the
patients attending the PTPBC beyond the physical therapy plan of care.

103

Related to physical activity and exercise, breathing exercises can be an entrypoint to pain control, health, and wellness for those particularly limited by
musculoskeletal pain. Breathing exercise have been shown to reduce blood pressure, help
with pain symptoms, and promote mental health.280-283 Briefly, purported mechanisms for
this include improved regulation of the autonomic nervous system as well as potential
musculoskeletal improvements in mobility of the spine and rib cage, lung capacity, and
control of postural/stabilizing musculature involved in respiration.280,281,283-286 A metaanalysis investigating the use of voluntary slow breathing exercises found that SBP could
be reduced by 6.36 mmHg (CI 95%: 10.32 to 2.39) and DBP by 6.39 mmHg (CI 95%:
-7.30 to -5.49) in randomized controlled trials of 2-weeks to 6-months in duration.282
While meta-analysis of breath therapy for patients with chronic nonspecific low back
pain is underway,287 previous studies in this population have demonstrated some
improvements in pain, function, and quality of life.280,288,289 However, breathing exercise
prescription and length of follow-up are variable in available studies on blood pressure,
pain, and mental health, making standardized treatment recommendations difficult. Much
like diet and exercise, adherence is an important consideration for breathing practice as it
relates to outcomes. Schmidt et al introduced a breathing intervention to patients with
painful temporomandibular disorders or fibromyalgia.283 Those who responded to this
intervention demonstrated significant changes in autonomic function as well as selfreport measures in the domains of fatigue and pain.283 Interestingly, those who responded
to the breathing intervention practiced on average 25-minutes per day, while those who
did not responded practiced on average only 15-minutes per day.283 Thus, adherence
strategies need to be explored when promoting long-term outcomes for patients.
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In regards to insomnia, management can be successful without pharmaceutical
management through the use of sleep hygiene290 and cognitive behavioral methods.291
Sleep hygiene focuses on avoiding stimulating substances, such as caffeine and nicotine,
in the hours preceding bed time.290 It also encourages relaxing activities before bed, such
as breathing exercises or warm baths, while avoiding stimulating activities, such as
exercise, engaging television shows, books, or computer work.290 Cognitive behavioral
therapy for insomnia (CBT-i) incorporates sleep hygiene, but also promotes techniques to
associate the bed with sleep only.292 For example, no other activities, with the exception
of sexual activity, are allowed while the patient is in bed. Sleep titration is another
important component of CBT-i, which has the goal of making the time in bed nearly
equal to the total sleep time.292 To achieve this, the patient participates in sleep journaling
to determine the amount of actual sleep they achieve per night versus the amount of time
they are lying in bed. Once this is established, the amount of time in bed is prescribed as
actual sleep time plus 30-minutes.292 The goal is to improve sleep quality first, then
slowly increase sleep quantity. If a patient is unable to improve sleep through sleep
hygiene and CBT-i, referral for medical management is indicated.293 The patient can
work with his/her medical practitioner to choose the best pharmaceutical intervention
based on characteristics such as medication half-life, side-effects, abuse risk, and
dependence risk.293 However, CBT-i has been recommended as the first-line treatment
for insomnia by the American College of Physicians.294 While poor sleep has been
demonstrated to be a risk factor for pain,118-120,295 disease,296-298 anxiety,95 depression,95-97
hypertension,98,99 and obesity,93,94 the impact of improving sleep on these comorbidities
remains understudied.
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To summarize, in order to improve physical health, mental health, and pain and
functional outcomes, the PTPBC will need to integrate on-site physical and mental health
providers into the physical therapy plan of care as well as establish our physical therapy
providers in the community pro bono medical clinics so that patients can access multiple
providers during a visit to the clinic. Efforts of the physical and mental health providers
can be supported through programming to assist patients with developing dietary,
physical activity, breathing, and sleep habits along with structured patient engagement
initiatives to promote adherence in these domains to promote health and wellness. By
doing so, an environment can be created to best support our clinical population, while
also reducing the burden on a single healthcare provider by distributing care and
engagement across multiple professionals and support staff.

6.2

Future Research Directions
Identifying the need for additional physical and mental health care management

opportunities for this clinical population, future research is needed on implementation
strategies for integrated care as well as the resultant outcomes across domains of pain,
physical health, emotional health, and quality of life. For example, if a patient with
chronic pain presents with severely limiting pain and symptoms of depression and
anxiety, similar to Class-one identified in this study, should the initial focus be working
with a mental healthcare provider before addressing needs in physical therapy, physical
fitness, and nutrition? Or, should all of these services be introduced concurrently? Based
on patient subgrouping, it may be that certain aspects of health and wellness require
greater emphasis initially to achieve outcomes across health domains in those specific
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populations. In other terms, sequencing of interventions and the emphasis placed on those
interventions may prove to be important in optimizing patient outcomes, as asking the
patient to make multiple changes in lifestyle at once may be overwhelming. Similarly,
within the domain of physical fitness itself; if a patient presents to the clinic with pain
complaints and low cardiovascular and musculoskeletal fitness, similar to Class-two in
this study, should exercise prescription initially include aerobic exercise, strength
training, motor control, and breathing training? Or, are outcomes improved when one is
introduced at a time? Direction on the prioritization of interventions, particularly for
unique patient subgroups, is needed. This would develop models for interdisciplinary
care and define patient pathways that then could be adopted by other clinics as well.
As mentioned, adherence to lifestyle changes are necessary to maintain health and
wellness. Therefore, strategies to improve adherence are another research target. Using
approaches to patient engagement such as telehealth, virtual check-ins, or automated
surveys/texts/emails, determining the proper amount of contact that keeps the patient
engaged without overburdening the patient is of interest. Likely, there will be different
patient groups with specific preferences about how much contact is appropriate and
therefore identifying these subgroups is important to tailor communication approaches to
the patient. Similarly, when connecting with patients remotely, monitoring objective
indicators that suggest the patient should return to the clinic for follow-up with a physical
or mental health provider would be useful along with patient report. For example,
psychosocial status could be monitored using the PSS-4, PHQ-4, and ISS, while physical
health monitoring could include blood pressure, BMI/WtHR, and 30-second sit-to-stand
test, or other psychosocial or physical health measures not investigated in this study.
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Monitoring these measures over time may help identify changes that fall outside of
normal variation, indicating a booster session with a healthcare professional is warranted.
Again, determining the proper frequency of these screening tests will be important so that
these measures can be meaningfully monitored without being burdensome to the patient.

6.3

Limitations
While the clinical population is of interest given the high prevalence of persistent

pain, the uniqueness of this clinic compared to those within the healthcare system will
limit external validity of the findings (e.g. an uninsured/minimally insured population
versus an insured population), as there are likely large differences in the social
determinants between these populations. The inclusion criteria for this study is
intentionally broad to capture the heterogeneity of people with presenting to the clinic
with pain, given the multifactorial causative factors demonstrated in the literature. Also,
clinical data is not as well controlled compared to the laboratory setting. While protocols
were in place to capture the included measures, the flow of the typical clinic day as well
as being a training facility for student physical therapists can introduce error to the
measurement. This has to be considered with interpreting the results of this study.
Also, while pain severity, chronicity, location, and description are important
variables in capturing the pain experience, additional items such as pain interference299
would have provided a much broader portrait of the effect of pain on the patient’s
functioning and measures of quality of life could have provided better insight to the
patient’s overall wellbeing. Also, including a tool such as the painDETECT300 or the
revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2)301 which ask
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more specific questions about the presence of neuropathic pain symptoms would have
allowed for more accurate patient grouping based on pain neurophysiology, separating
out those with features related to neuropathic pain which has a different underlying
pathophysiologic mechanisms compared to musculoskeletal pain. Similarly, including
clinical measures suggested by the Pain-Oriented Sensory Testing (POST) guidelines302
to test for dynamic mechanical, punctate mechanical, pressure-evoked, and cold allodynia
would help inform grouping based on pain neurophysiology.
Last, given that diagnosis of medical and mental health conditions fall outside of
the scope of physical therapy practice, subjects were grouped by potential risk of these
conditions rather than a more definitive diagnosis from medical or mental health
provider. These measures included MetS, aerobic capacity, anxiety, depression, PTSD,
OSA, and sleep disturbance. Having a diagnosis from a medical or mental health provider
would allow for a better comparison of whether those with these conditions are
significantly different from those without these conditions.

6.4

Conclusion
The first aim of this study was to statistically describe the population attending

the PTPBC in the domains of socioeconomic, physical, and emotional health as well as
pain complaints. This analysis identified that the majority of patients presented with long
standing pain complaints, described a lower socioeconomic status, presented with
comorbid emotional health conditions near or above the rate of the general population,
and scored particularly poorly on physical health measures related to blood pressure,
body mass, pulmonary function, and lower body strength and endurance. Thus,
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improving the patient population’s health and wellness in these domains can lead to
improvements in quality and longevity of life.
The second aim of this study was to determine which physical and emotional
health measures could be used to better inform MetS in a clinical setting without access
to laboratory values. Only SBP and waist circumference were found to be predictive of
MetS risk, therefore no novel measures to inform clinical reasoning were identified in
this study. Practitioners should continue to use blood pressure and waist
circumference/WtHR to screen for MetS risk when laboratory values are not available.
The third aim of this study was to determine if significant difference between
groups existed between those “at-risk” for MetS and those not at risk. Given the similar
physiology and risk factors between MetS and musculoskeletal pain, it was hypothesized
that those “at-risk” for MetS would demonstrate poorer scores in the domains of physical
health, emotional health, and pain. Ultimately, there was only an approximate 10-20% in
scores on select physical health measures between groups. No additional meaningful
differences were discovered, meaning that MetS risk was not a useful subgrouping to
inform the patient’s pain presentation using the measures included in this study with this
clinical population
The final aim of this study was to identify unique patient subgroups within the
sample that may require a more tailored plan of care based on needs. Using latent class
analyses, three groups were identified. The only group presenting with a high pain
experience using the domains used in this study was Class-one, which also demonstrated
greater emotional health involvement. Class-two and Class-three presented with a lower
pain experience, with Class-two demonstrating poorer pulmonary function and upper
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extremity strength than Class-three. Thus, in regards to pain, emotional health may
impact the patient’s pain presentation greater than physical health.
In conclusion, many opportunities to improve the physical, emotional, and
socioeconomic health of the population attending the PTPBC. Novel methods to
clinically determine MetS in absence of laboratory values were not discovered and MetS
risk was not identified as a useful strategy to subgroup patients with pain complaints
attending the clinic. While measures of physical health and emotional health are useful in
measuring the health status of the patient, poorer scores on emotional health measures
were more often in present in patients describing a greater pain experience in this sample.
Therefore, while employing strategies to raise the physical, emotional, and
socioeconomic health of the clinical population can support increased quality and
quantity of life, addressing emotional health may most greatly impact pain outcomes.
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